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ABSTRACT 
 Prior nutrigenetic studies on the interaction between limiting vitamin A (VA) and 
the ADH1Cc.-64T>C SNP have shown that TT animals with reduced VA intake have 
improved intramuscular fat (IMF) in the longissimus thoracis muscle in beef cattle. The 
intent of this study was to determine whether this marker-assisted management (MAM) 
strategy would be effective at a commercial level, and whether there would be any 
immune function ramifications from limiting dietary VA. This occurred in two separate 
experimental groups, the first being a smaller immunology population, and the second in 
a large-scale commercial feedlot.  
 Crossbred steers (n = 18), black in colour, were selected from a prior feeding trial 
so that all combinations of ADH1C genotype (TT, CT, and CC) and VA level (25% or 
75% of NRC, 1996 recommendations) were equally represented. Blood cell count 
analysis, peripheral blood mononuclear cell (PBMC) proliferation and stimulation assays, 
and quantitative reverse transcription polymerase chain reaction (qRT-PCR) examination 
of cytokine expression were conducted and compared. Vitamin A did not affect any of 
the measured parameters, and any significant (P < 0.05) pen and genotype effects did not 
equate to clinically ill animals.  
 The second study population included 2000 mixed breed beef steers, separated 
into 40 feedlot pens. Genotype at ADH1C (TT or CT), VA level (50% or 100% of NRC, 
1996 recommendations), and implant status (IMS; implanted or non-implanted, IMP or 
NI respectively) were all equally represented with 5 pens of each possible combination of 
variables. Production and carcass data were collected, and the expected VA X ADH1C 
interaction effect was not observed. An IMS X ADH1C interaction effect was observed 
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with average daily gain (ADG; P=0.03), and IMS alone had significant effects on dry 
matter intake (DMI; P<0.01), total days-on-feed (P<0.01), USDA yield grade (P<0.01), 
marbling score (P<0.01), rib-eye area (REA; P=0.01), and backfat thickness (P<0.01). 
Overall, IMP animals finished on fewer days-on-feed with higher ADG, DMI, and REA 
and lower yield grades, marbling scores, and backfat thickness. No other interaction or 
main effects were observed, suggesting that the ADH1C X VA nutrigenetic MAM 
strategy is not effective at a feedlot level at this time.  
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1. INTRODUCTION 
Marbling in beef is important to both producers and consumers. Premiums are offered on 
grading scales for carcasses that score above a certain level of marbling (DiCostanzo and 
Dahlen, 2000). Marbling is an important determining factor in the food purchasing 
decisions of beef consumers, as they tend to search for juiciness, flavour, and an overall 
enjoyable taste experience (Wheeler et al., 1994). The widespread use of growth 
promotants in North America has however, shifted the quality of beef in the opposite 
direction of consumer demand, while increasing overall lean meat yield (King et al., 
2012), which is economically beneficial. This shift has caused an increase in research 
surrounding improving marbling through the reduction of dietary vitamin A (VA), with 
mixed results. 
Altering management strategies based on genotype to improve efficiency is 
referred to as marker-assisted management (MAM). A proposed MAM strategy is 
feeding limiting levels of VA to TT animals at the alcohol dehydrogenase 1 C 
(ADH1Cc.-64T>C) single nucleotide polymorphism (SNP) to improve marbling in beef 
cattle (Ward et al., 2012). Steers that are TT could be targeted for carcass quality, taking 
advantage of premiums, while CT and CC steers would be sold on live weight or hot 
carcass weight.  This strategy takes advantage of the role of VA and its retinoids in the 
process of adipogenesis. The ADH1Cc.-64T>C SNP was thought to remove a 
transcription factor binding site, decreasing its expression, and decreasing the level of 
intramuscular fat (IMF) in animals with the mutation when VA was limited (Ward et al., 
2012).  
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Limiting dietary VA for improvements in marbling, and therefore potential 
profits, comes with the additional responsibility of ensuring that animal welfare is not 
hindered by possible deficiency. Symptoms ranging from decreased average daily gain to 
death can all be attributed to VA deficiency (Wolbach and Howe, 1925; Smith et al., 
1987; NRC, 1996). Vitamin A and its retinoids play important roles in vision, 
reproduction, and immune function, alongside their roles in adipogenesis. Specifically, 
failures of immune function due to VA deficiency could be catastrophic in a feedlot 
setting given that animals enter the feedlot with varying levels of stored VA, and tend to 
face several periods of stress and disease challenge throughout their time there.  
 The goal of this research was to determine whether feeding an intermediate level 
of VA (50% of NRC recommendations) in finishing rations to TT animals at the 
ADH1Cc.-64T>C SNP in a commercial feedlot setting would improve marbling. 
Observing the effect of hormonal implants on the ADH1C X VA MAM strategy, as well 
as classifying any signs of immune function deficiency were additional objectives. 
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2. LITERATURE REVIEW 
 
2.1. Vitamin A 
Vitamin A (VA) is a fat-soluble vitamin, and is ingested primarily in the form of β-
carotenoid in feedlot rations (Eroglu et al., 2012). This form of pro-vitamin A is easily 
converted to retinol (ROL; Figure 2.1.1.) within the body (Deming and Erdman, 1999). 
While the form of VA found in animal sources (retinyl esters) can be transformed 
through hydrolyzation to ROL in the lumen of the intestine (Blomhoff et al., 1990; 
Harrison, 2005), carotenoids can either remain intact or be transformed to ROL through a 
cleaving process (Harrison, 2005). In the cytosol of enterocytes, alcohol dehydrogenase 
(ADH) is the enzyme responsible for converting ROL to retinaldehyde (RAL). The 
oxidization process from RAL to retinoic acid (RA) is completed by the enzyme 
retinaldehyde dehydrogenase (RALDH; Duester, 2000). While RALDH only completes 
its forward reaction, ADH is able to convert from one retinoid to another in the forward 
and reverse directions (Boleda et al., 1993).  
The liver acts as a primary depot for VA within the body, and when carotene 
intake is in excess, VA can also be stored in fat cells. When dietary VA is limiting, the 
mobilization of stored VA from the fat and liver can occur, delaying the occurrence of 
VA deficiency (McDowell, 1989). Stored liver VA varies in a coordinated way with 
fluctuations in VA intake (Bryant et al., 2010; Ward et al., 2012; Pickworth et al., 2012). 
Retinol-Binding-Protein-4 is able to bind ROL and mobilize it from the liver and into the 
circulatory system (Quadro et al., 2004; Blomhoff, 1990). The concentration of VA in the 
blood depends on both VA intake and liver stores (McDowell, 1989). 
 4 
 
 
Figure 2.1.1. Diagaram depicting the relevant steps of the vitamin A pathway that involve the 
alcohol dehydrogenase 1C (ADH1C) enzyme. (RBP = Retinol binding protein; RALDH = 
Retinaldehyde dehydrogenase enzyme; RXR = Retinoid X nuclear receptor; RAR = Retinoic acid 
nuclear receptor; RARE = Retinoic acid response element transcription factor) 
 
2.1.1. The Importance of Vitamin A 
Vitamin A is important for the proper functioning of a wide spectrum of bodily functions, 
including: vision, bone and tooth development, reproduction, epithelial development, 
immune function, cell division and differentiation, adipogenesis, and maintaining 
moisture in mucous membranes, skin, and eyes (Goodman, 1984; Dawson, 2000; 
Anderson and Young, 2008). These effects of VA often occur by means of changes in 
gene expression. Humans living in developed nations tend to be more concerned with VA 
toxicity than being deficient, likely due to the often sufficient levels of VA in a typical 
daily diet combined with high concentrations of VA in some multivitamin supplements. 
Early symptoms of VA toxicity are loss of appetite, headache, nausea, and itchiness, 
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while more severe acute toxicity symptoms include dizziness, blurred vision, growth 
impairment, and birth defects. Night blindness and over-keratinized skin are early 
symptoms of VA deficiency, while long-term effects include: reduced immune function, 
delayed tooth and bone development, birth defects, seizures, and mortality. 
 The concern for VA levels in cattle diets tends to revolve around avoiding 
deficiency, as toxicity would be difficult to achieve, and the symptoms of deficiency 
would be quite costly to the producer and would have animal welfare repercussions. 
Early symptoms of VA deficiency in cattle often include inefficiencies in production 
traits, followed by weakness, ataxia, blindness, xerophthalmia, convulsions, syncope, and 
reproductive issues (Radostitis et al., 2000). Appetite, coat condition, presence of night 
blindness, swelling of the joints, drooling, and general ill behaviour were all indicators 
used by Kruk et al. (2008) to assess their study animals for VA deficiency. Spears (2000) 
stated that there was a clear link between VA deficiency, infectious disease occurrence, 
and mortality. The effect of VA deficiency on immune function is therefore a large 
concern for cattle producers. Consequently, feedlot rations often surpass the required 
2,200 IU/kg dry matter (NRC, 1996), to eliminate the concern of clinical VA deficiency 
altogether. 
 
2.1.2. The Effect of Vitamin A on Immune Function  
Over-feeding of VA to feedlot cattle is common but may have a negative impact 
on carcass quality. As a result, reduced VA supplementation may be a strategy that can 
be implemented in the future to improve marbling. However, the following 21 immune 
functions have been reported to be affected by retinoids: keratinization; hematopoiesis; 
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apoptosis; ICAM-1 expression; mucin, immunoglobulin, TNF-α, TGF-β, phospholipase 
A2, IFN-γ, IL-1, IL-2, IL-3, and IL-4 production; neutrophil, natural killer cell, 
monocyte/macrophage, Langerhans cell, T lymphocyte, cytotoxic T lymphocyte, and B 
lymphocyte function (Semba, 1998). Clearly, retinoids have a vast array of effects on 
immune responses, encompassing physical barrier properties, innate, and acquired 
immune responses. Deciphering between the effects of VA deficiency on immunology 
and the effect of disease on VA deficiency is not an easy task. The relationship between 
the two is quite cyclic in that VA deficiency lessens the immune system’s ability to 
defend against infectious disease, and infectious disease can greatly reduce the uptake 
and absorption of VA, while also increasing its excretion (Stephensen, 2001). Before 
reduced VA supplementation is implemented, the effect of this strategy on markers of 
immune function and animal health should be evaluated. 
The first lines of defense in mammalian immunity are physical barriers and innate 
immunity. Vitamin A deficiency primarily affects physical barriers through an overall 
reduction in mucosal immunity due to the loss of goblet cells and reduction of mucin and 
mucus production in the respiratory, gastrointestinal, and urogenital tracts (Stephensen, 
2001). This decrease in mucin and mucus production is harmful for three reasons: 1) 
mucus is important because it allows for the trapping and expelling of invaders; 2) mucus 
also provides a protective barrier for underlying epithelial cells; and 3) mucosal epithelia 
are less capable of regenerating (Stephensen, 2001). Once epithelial cells on the mucosal 
surface are exposed, squamous metaplasia, necrosis, and inflammation can occur 
(Stephensen, 2001), all of which are risk factors for the systemic spread of pathogens. 
Immune deficiencies reported in animals lacking VA lead to an increased risk of invasive 
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disease and mortality, even if improved availability of VA through dietary 
supplementation may reverse physical barrier damage (Stephensen, 2001).  
The recognition of pathogen-associated molecular patterns by pattern recognition 
receptors such as Toll-like receptors is central to the function of the innate immune 
system (Medzhitov and Janeway, 1997). Neutrophils are incredibly efficient at 
phagocytosing and destroying extracellular infectious agents and the available evidence 
shows that their killing ability is diminished in VA deficient animals (Semba, 1998; 
Stephensen, 2001). This is likely due to the fact that the VA nuclear receptor retinoic acid 
receptor (RAR) regulates the expression of genes involved in neutrophil development 
(Stephensen, 2001). Macrophages also phagocytose, but function as antigen presenting 
cells as well as destroying the foreign infectious agent. They present antigens on their 
major histocompatibility complex II molecules, which can then be recognized by T 
helper cells to drive cell- or antibody-mediated immune responses in the presence of the 
appropriate co-stimulatory signals (Mosmann and Coffman, 1989; Stephensen, 2001). 
Macrophages are also affected by retinoids in that they have a reduced phagocytic ability 
in VA-deficient animals (Semba, 1999; Stephensen, 2001). All cells that do not display 
normal cell signals (non-self, often virus-infected or tumor cells) are recognized by 
natural killer cells, which then destroy them (Stephensen, 2001). In VA deficient animals, 
both natural killer cell numbers and killing ability are diminished (Semba, 1998; 
Stephensen, 2001).  
T and B cells of the acquired immune system are very much interconnected, 
where by a change in function of one cell type is likely to affect the other. During VA 
deficiency, antibody-mediated immune responses tend to be more significantly affected 
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(Stephensen, 2001). Vitamin A deficient animals have been shown to demonstrate 
reduced lysing ability of cytotoxic T cells, but T helper 2 cells are the most affected, as 
their functioning is significantly impaired (Semba, 1998; Stephensen, 2001).  These 
larger-scale effects of VA levels on lymphocytes may be due to the fact that retinoids are 
present within every lymphocyte subset in humans (Semba, 1998). Interestingly, the T 
helper 1 cell response is unaltered or even improved by VA deficiency in humans 
(Stephensen, 2001). It is hypothesized that this is due to a shift from a TH2 to a TH1 
response. This shift is characterized by a decrease in IL-4, IL-5, and IL-10 cytokines and 
an increase in IFN-γ and IL-12 cytokine release (Semba, 1998).  
These effects of VA deficiency on immune function are incredibly relevant to the 
feedlot industry, where animals face high stress environments and disease challenge 
frequently. Stress has been shown to be immunosuppressive, depressing T cell responses, 
natural killer cell function, and IL-2 production (Tizard, 2000). Bovine viral diarrhea 
virus (BVDV) is an example of a condition that could be exacerbated by the negative 
effect of VA deficiency on immune function. It is common in feedlots, resulting in large 
annual losses in production and profit. The cytokine IL-1 is critical in both innate and 
acquired immunity, and its inhibition during a non-cytopathic BVDV infection has been 
suggested (Peterhans et al., 2003). In addition to reduced cytokine and co-stimulatory 
signaling of IL-1, BVDV infection may also lead to irritation of the gut epithelium, and 
therefore the VA deficiency effects previously discussed could be devastating to affected 
feedlot populations.  
The appearance of VA deficiency symptoms was obvious in a group of 
extensively grazed beef cattle during one year on poor pasture. The effects were most 
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prominent in newborn calves, even when their dams did not show signs of clinical 
deficiency (Hill et al., 2009). Over 40% of the calves born in this herd died, with the 
majority being stillbirth, in addition to a high incidence of prenatal loss. Hill et al. (2009) 
concluded that VA deficiency likely played a large role in the deaths of these animals as 
their serum and liver VA levels were deficient or undetectable. Hepatic storage of VA is 
known to buffer extended periods of poor feed quality and the period of deprivation is 
often not long enough for deficiency symptoms to occur (Radostitis et al., 2000). This is 
an extreme example of VA deficiency within a beef cattle herd, and outlines the 
difference in buffering capacity between dam and calf on poor quality forage.  
 In theory, all of the effects of VA deficiency on immune function would be quite 
harmful with respect to the acquired immune system and its antibody-mediated 
responses, but in reality this is not always the case. Jee et al. (2013) discovered that 
antibody titers did not significantly differ between calves fed 3300 IU VA/kg DM versus 
1100 IU VA/kg DM per day after receiving multiple vaccinations. The antibody response 
to an ovalbumin vaccine was not affected by VA restriction in a study by Gorocica-
Buenfil et al. (2014) where animals were fed either no supplemental VA or the 
recommended 2200 IU/kg DM supplement for 216 days. The immune response of 
newborn Holstein calves fed 0, 5000, 10 000, and 20 000 IU VA/day also did not differ 
over a 56 day period (Hidiroglou and Markham, 1996). These findings are important as 
they suggest that a fairly severe level of VA deficiency may be necessary before 
biologically significant alterations in immune responses take place. 
Immune responses in vertebrates are quite difficult to discuss separately, as 
physical barrier function, innate, and adaptive immune responses are all linked. In 
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addition to that complexity, VA deficiency can be the result of insufficient dietary intake, 
improper absorption, excess excretion, due to prolonged illness, or any combination of 
these factors. This could be of significant concern for production, as animals entering a 
feedlot have been on varying qualities of pasture or feed, will face multiple disease 
challenges or may be chronically ill, and will generally be under stress multiple times 
during their stay. Although reaching a level of VA deficiency in many animals is likely 
difficult to achieve, once at that level, this vicious cycle of dampening the immune 
response and disease causing further deficiency could be difficult to break without 
intensive and likely expensive treatment.  
 
2.1.2.1. Cytokine Gene Expression Methods of Analyzing Immune Function 
Quantitative Polymerase Chain Reaction (qPCR) is based around the process of gene 
amplification that is accomplished through typical PCR, with the added ability to 
determine the amount of amplification occurring, or the original amount of genetic 
material in the sample. In Reverse Transcription Polymerase Chain Reaction (RT-PCR), 
RNA is reverse-transcribed to cDNA to be used for PCR, which therefore demonstrates 
the amplification of genes that are actively transcribed in a specific cell/tissue of interest. 
Additionally, the ability to monitor amplification during a PCR run is possible through 
Real-Time PCR (Ginzinger, 2002; Bustin et al., 2009). Any combinations of these 
methods are commonly used to analyze gene expression. Cytokine gene expression, 
disease susceptibility polymorphism genotyping, and viral load determination can all be 
assessed through the use of qRT-PCR, making it a very useful tool in many fields, 
including immunology. 
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 The analysis of qRT-PCR data can occur by two general methods, absolute 
quantification and relative quantification. Both methods depend on the generation of an 
amplification curve. This curve demonstrates the required number of PCR cycles that 
would create enough fluorescence to surpass the pre-determined threshold level or value 
(Ct; Giulietti et al., 2001). The Ct and the original amount of nucleic acid in the starting 
material are therefore inversely proportional, and the doubling of the amount of product 
at every cycle is the basic assumption of PCR (VanGuilder et al., 2008).  
The creation of a standard curve for the gene of interest is required for the 
absolute quantification qRT-PCR method, where each point on the curve would be of 
known copy number. Comparisons can then be made against this curve to determine the 
specific number of nucleic acid copies in the tested sample through its experimentally 
obtained Ct value. Not all genes of interest are accessible in known concentrations; 
therefore the creation of a standard curve may not always be possible (Giulietti et al., 
2001). 
Relative quantification requires the use of a housekeeping gene (ie. Beta-actin, 
GAPDH, ribosomal proteins) that functions as an external control. Housekeeping genes 
must only be selected if their expression is unaltered by the experimental treatments 
(Giulietti et al., 2001). The Ct values of the gene of interest as well as the housekeeping 
gene are then compared in the following formula:  
ΔΔCt = ΔCt (test) – ΔCt (control);  
where ΔCt (test) = Ct gene of interest (test) – Ct housekeeping gene (test),  
and ΔCt (control) = Ct gene of interest (control) – Ct housekeeping gene (control).                          
An additional correction of 2-ΔΔCt must then be used to determine the relative quantity 
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value if relative quantification comparisons are required. If the amount of product 
doubles after the completion of each amplification sample, this correction is the only 
value that is statistically correct when making comparisons between relative 
quantification values (VanGuilder et al., 2008). The efficiency, accuracy, and precision 
of today’s qRT-PCR (Ginzinger, 2002) along with its multiple options for chemistry and 
analysis method allow for it to be useful for diverse applications in many different 
disciplines. 
More specifically, the application of RT-PCR in assessing cytokine gene 
expression is commonly used to determine and explain the level of immune 
responsiveness in cattle. When infected with Mycobacterium bovis (Thacker et al., 2007) 
or Cooperia punctata (Bricarello et al., 2008), cytokine gene expression was studied as a 
marker for the immune function of Holstein and Nelore cattle, respectively. Expression of 
IL-2, IL-4, IL-5, IL-10, IFN-γ, and TNF-α were analyzed by means of RT-PCR to study 
immune competence and inflammation precursors in Holstein cattle inoculated with 
differing lines of S. aureus (Luby, 2010). Additionally, RT-PCR can be used to determine 
the effect of vitamins on cytokine expression. Li-Weber et al. (2002) studied the effects 
of vitamin E on human peripheral blood T cells by means of RT-PCR and concluded that 
vitamin E suppresses IL-4 transcription. Vitamin A is also known to influence gene 
expression, which has multiple downstream effects.  
 
2.1.3. The Role of Vitamin A in Gene Expression and Adipogenesis  
As mentioned previously, VA plays a role in many systemic bodily functions. Its effect 
on adipogenesis is intrinsically linked to how VA alters gene expression. The RA and 
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RAL retinoids are able to act in opposing manners on the expression of genes involved in 
adipogenesis through their interactions with nuclear receptor proteins. The retinoic acid 
receptor (RAR) and retinoid X receptor (RXR) are both able to bind to RA, which then 
allows them to form either homo- (with the same receptor type) or hetero- (with the other 
receptor type) dimers (Heyman et al., 1992; Repa et al., 1993; Petkovich, 2001; 
Desvergne, 2007). Within the promoter region of many genes lie retinoic acid response 
elements (RAREs) that these RAR/RXR homo- or hetero-dimers bind to (Heyman et al., 
1992; Zhang et al., 1992), potentially altering the expression of that gene. Up-regulation 
of transcription is the common outcome of RA binding to RAR/RXR dimers that then 
bind to RARE (Heyman et al., 1992; Zouizenkova et al., 2007), while RAL is thought to 
do the opposite through acting as a substrate in competition with RA. Other nuclear 
receptors, including peroxisome proliferator-activated receptors, vitamin D receptors, 
thyroid hormone receptors, and liver X receptors, are also able to form heterodimers with 
RXR (Bugge et al., 1992; Zhang et al., 1992; Bardot et al., 1993; DiRenzo et al., 1997; 
Desvergne, 2007; Ziouzenkova et al., 2007), which may also affect gene expression.  
The intricate maturation process of pre-adipocytes to adipocytes is termed 
adipogenesis, which can be altered by VA. Essentially, multipotent stem cells can be 
influenced by the presence or absence of VA, to become pre-adipocytes through 
hyperplasia (Harper and Pethick, 2004). When applied to embryonic stem cells, RA is 
able to cause large amounts of adipogenesis (Gregoire et al., 1998), and the inhibition of 
fat deposition is possible with sufficient levels of RAL (Ziouzenkova et al., 2007) or 
ROL (Kawada et al., 1996). This stimulation process by RA may be effected by the 
interaction of the retinoid receptors RAR and RXR (Mizoguchi et al., 2014) with the 
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RARE complex, which alters gene expression, and therefore up- or down-regulates the 
expression of genes key to adipogenesis (Zhang et al., 1992).  
 
2.1.4. Implementation of Vitamin A Restriction in Beef Cattle  
The recommendation for dietary VA for feedlot cattle, as determined by the National 
Research Council (NRC; 1996), is 2200 IU/kg dry matter. This recommendation 
however, is often surpassed, sometimes doubled or tripled in today’s feedlot management 
systems. The over-feeding of VA at these levels is not typically a concern for 
hypervitaminosis, but with knowledge of RAL impeding fat deposition (Ziouzenkova et 
al., 2007; Kawada et al., 1996), and all-trans retinoic acid inhibiting adipocyte 
differentiation (Ohyama et al., 1998; Kawada et al., 2000), research has been conducted 
to determine the potential benefits of limiting VA in feedlot diets.  
 Wagyu steers have been shown to have an increase in marbling with a decreased 
intake of beta-carotene (Oka et al., 1998) and when blood levels of VA were low (Adachi 
et al., 1999). Similar findings have also shown in beef breeds in North America. Kruk et 
al. (2008) found that Angus cattle, unsupplemented for VA, had no symptoms of 
deficiency, but did have: 35% higher IMF (P < 0.0026); numerically higher US marbling 
scores (P = 0.094); 33% higher seam fat (P < 0.05); lower VA concentrations in 
extrahepatic tissues and fat; and lower melting points of the subcutaneous fat than their 
supplemented counterparts. The lower melting point of this fat suggests a softer, more 
unsaturated fatty acid-rich (Siebert et al., 2000) desirable fat. A significant negative 
correlation between serum ROL and marbling scores was also found (Kruk et al., 2008), 
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demonstrating that this association between VA and marbling does not solely occur in 
Wagyu cattle.   
 Angus crossbred steers fed an unsupplemented diet for VA had significantly 
improved quality grades and tended (P = 0.06) to have increased ether extracted IMF 
(Pickworth et al., 2012a). Results also demonstrated significant interaction effects of VA 
and vitamin D supplementation on backfat thickness and USDA Yield grade, where both 
backfat thickness and yield grades were decreased with VA and vitamin D 
supplementation. These traits are related however, and there was no interaction effect on 
IMF, therefore VA is likely the main contributor of the two to fat deposition, at least with 
respect to quality grade. 
 Studies have also found evidence to refute these associations.  Bryant et al. (2010) 
found no difference (P > 0.10) in marbling score, hot carcass weight (HCW), longissimus 
thoracis (LT) muscle area, and 12th-rib fat thickness among all VA supplementation 
treatment levels (0, 1103, 2205, 4410, and 8820 IU/kg DM) for a group of yearling black 
feedlot steers. Gorocica-Buenfil et al. (2008) also found no effect (P > 0.10) of VA 
restriction in Angus-based steers on ADG, DMI, G:F, HCW, 12th-rib fat, yield grade, 
marbling score, and IMF measures. Animals that received zero supplemental VA did 
have reduced serum (P < 0.01) and liver (P < 0.01) ROL levels when compared to 
animals supplemented at the NRC (1996) recommendations, suggesting that the 
restriction was able to reduce stored and circulating VA within the body (Gorocica-
Buenfil et al., 2008). However, monounsaturated fatty acids (MUFAs) were observed to 
increase (P = 0.03) in unsupplemented animals, while saturated fat levels decreased (P = 
0.03). This finding was in agreement with the results on fatty acid content by Kruk et al. 
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(2008), and suggested a potential effect of VA restriction on desaturase enzyme activity 
(P = 0.01).  
 These mixed results are typical in the VA restriction literature and could, in part, 
be due to the timing and duration of restriction.  Pickworth et al. (2012b) found that both 
serum and hepatic VA in Angus crossbred steers were significantly highest at 56 days 
after cattle were weaned and arrived in the feedlot, for all levels of VA supplementation. 
The hepatic VA stores were reduced, and remained at low levels when animals remained 
unsupplemented. While growth traits and USDA yield grades were not affected by VA 
restriction, IMF in the (LT) muscle increased in unsupplemented animals. It has been 
suggested (Pickworth et al., 2012b; Kruk et al., 2008) that the level of restriction is not 
the sole factor in improving fat deposition, and that the duration of said restriction may be 
equally important. With proper timing and implementation, feedlot limitation of VA has 
the potential to increase quality grades, IMF, or MUFA content, in turn possibly 
increasing profits. However, the quality of pasture that animals are raised on or 
backgrounded on must be considered, as unsupplementing VA in the finishing ration may 
cause severe losses with respect to VA deficiency.   
 
2.1.5. Nutrigenetics of ADH1C and Vitamin A 
The way in which food components affect gene expression is nutrigenomics, while 
nutrigenetics refers to the effect certain genetic mutations have on this process. Prior 
work on the interaction between limiting dietary VA and a mutation in the ADH1C gene 
has been performed in black coloured beef steers (Ward et al., 2012; Krone et al., 2016) 
with encouraging results with respect to producing better-marbled beef. Ward et al. 
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(2012) discovered a mutation in the promoter region of ADH1C (ADH1C c.-64T>C) that, 
when changed from a thymine to a cytosine base at position 64 upstream of the start 
codon, removes a binding site for the transcription factor CCAAT/enhancer-binding 
protein α (C/EBPα). The ADH1C gene produces the protein that oxidizes retinol (ROL) 
to RAL, which can be further oxidized to RA by RALDH (Duester, 2000). Napoli (1996) 
found that RALDH activity increased threefold when VA was deficient.  
 The ADH1Cc.-64T>C SNP has been found to affect gene expression (Ward et al., 
2012) and levels of ADH1C protein in liver tissue (Krone et al., 2016). Less ADH1C 
would impact the level of RAL, ultimately affecting the level of RA generated.  As 
mentioned previously, the expression of numerous genes in the adipogenesis pathway can 
be altered by RA and/or RAL, which act as ligands for RXR and RAR receptors that 
interact with one another as well as with the RARE to influence gene expression 
(Ziouzenkova et al., 2007). This typical up- or down-regulation of adipogenesis genes 
may be affected by the reduction in ADH1C expression when C/EBPα is removed with 
the C allele. This is because TT animals were found to have 22.9% higher levels of IMF 
than CC animals, when both sets of animals were unsupplemented for VA (Ward et al., 
2012). Unsupplemented TT animals had 24.4% higher IMF than other TT animals 
receiving the recommended 2200 IU/kg DMI VA levels (NRC, 1996; Ward et al., 2012). 
The nutrigenetic interaction between the ADH1C SNP and level of VA on IMF could be 
useful in a MAM strategy for feedlots where animals could be sorted based on genotype 
and TT animals could be fed limiting VA levels in order to market them on a marbling 
grid. However, the appropriate level of dietary VA, in order to avoid the complications of 
VA deficiency, still had to be determined.  
 18 
 Krone et al. (2016) set out to establish an appropriate level of VA inclusion for 
feedlots that in combination with the ADH1C SNP would improve consistency in carcass 
quality.  They fed limiting amounts of VA (25, 50, and 75% of NRC, 1996 
recommendations in a monthly oral bolus) in finishing rations of black feedlot steers. The 
expected effect of increased marbling for animals with the TT genotype was only 
significant (P < 0.05) at the 75% of NRC (1996) level.  This may have been due to the 
lack of variation in IMF levels at the 25% and 50% VA diets, as these animals 
consistently finished well above the Canada AAA baseline (Krone et al., 2016). The 
animals studied by Ward et al. (2012) were also fed VA deficient diets through the 
backgrounding period, while Krone et al. (2016) fed their study animals a normal 
backgrounding ration that included 1.7 times the NRC (1996) recommendation of VA 
due to available feedstuffs being high in VA that year. Krone et al. (2016) confirmed that 
TT animals had significantly (P = 0.02) higher ADH1C protein levels in liver tissue than 
CT and CC animals, and that there was significantly (P = 0.03) higher ADH1C protein 
levels in all animals at the end of test compared to concentrations in the liver at the start 
of test. This confirmed that the removal of the C/EBPα in animals with a C allele does in 
fact reduce the expression of the ADH1C gene, resulting in less ADH1C protein available 
to convert ROL to RAL. Nutritional background and the genetics of the animal are 
important factors impacting the growth potential of beef cattle (Platter et al., 2003; Bruns 
et al., 2005), and therefore combining the two in MAM strategies for feedlot use could 
offer great benefits for producers. These strategies however, would need to work in 
harmony with growth promotants as they are commonly used in feedlots today. 
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2.2. Effects of Hormonal Implant Use in Beef Cattle Production 
Hormonal implants are commonly used in commercially raised beef animals, in fact, 22 
different hormonal implants are listed on the CFIA website as being approved for use. 
Trenbolone and zeranol preparations are the two types of exogenous preparations that are 
approved, and several endogenous preparations such as progesterone and estradiol are 
also approved in Canada (CFIA, 2014). The recommended implant site for all hormonal 
implants is the ear, and animals may be implanted several times throughout their lives, 
however implants in animals intended for veal meat are not permitted (CFIA, 2014). 
 The purpose of these implants is to improve production and carcass traits with the 
overall end-goal of an increased return on investment for producers. A meta-analysis 
reviewing the effects of implants on beef cattle found significant increases in average 
daily gain (ADG) for implanted heifers and in ADG, DMI, and gain to feed ratio in 
implanted steers (Wileman et al., 2009). The study by Wileman et al. (2009) also 
estimated a decreased cost of production of $77 per implanted steer when compared to 
non-implanted steers. This reduction became more drastic, at $349 per implanted steer, 
when compared to organically raised steers (Wileman et al., 2009).   
Trenbolone acetate (TBA) is an exogenous preparation used in many beef cattle 
implants as a synthetic form of testosterone. It is often combined with some level of 
estradiol, which is a highly potent anabolic steroid, and these combination implants tend 
to be highly effective in improving production traits. Foutz et al. (1997) found that steers 
given an estrogen plus TBA steroid implant gained faster, and had improved feed 
efficiency than control or estrogen plus progesterone implanted animals. Steers receiving 
implants with TBA all had significantly larger LT areas, and a trend for lower marbling 
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scores and yield grades. A trend was also observed between increased shear force values 
for implanted steers versus controls (Foutz et al., 1997).  
 The number of implants also plays a role in production characteristics and carcass 
traits. Platter et al. (2003) found that implanted animals had significantly lower marbling 
scores, increased ADG from weaning to harvest, and increased LT muscle area compared 
to non-implanted groups. A panel of consumers rated steaks from non-implanted animals 
as more desirable for overall eating experience than steaks with 2, 3, 4, or 5 implants 
throughout their lives, regardless of the timing of these implants (Platter et al., 2003). 
Interestingly, Platter et al. (2003) also found that among the implanted animals, those 
with 2 lifetime implants had higher marbling scores than those from more aggressive 
implant strategies (4 and 5 lifetime implants). 
  Overall, hormone implants can improve yield and ADG, but may also greatly 
reduce quality in the form of marbling and eating experience – especially when 
aggressive implanting strategies are used. A negative public opinion regarding the use of 
hormonal implants in beef production is growing, and organic foods are increasingly 
trendy, suggesting a large market for hormone-free and organically raised beef. Due to 
these factors, Platter et al. (2003) suggest that producers decide on a customized implant 
strategy based on marketing intentions. 
 
2.3. Beef Cattle Markets and Consumer Preferences 
Beef consumers today are often able to distinguish between tenderness (Boleman et al., 
1997; Shackleford et al., 2001) and marbling levels in steak. These consumers are also 
willing to pay premiums for tender (Boleman et al., 1997; Shackleford et al., 2001) and 
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more marbled beef (Killinger et al., 2004). However, the consistency of beef quality has 
long been a significant problem according to those purchasing these products (Savell et 
al., 1987). There are also problems with grading differences, whereby depending on the 
cut of the meat, consumers often cannot tell the difference between a Low Choice and 
High Select (or Low Canada AAA and High Canada AA) or between Low Select or High 
Select (or Low Canada AA and High Canada AA; Neely et al., 1998). However, in the 
study by Neely et al. (1998), consumers were able to differentiate between High Choice 
(or High Canada AAA) steaks from the other grades in top loin and top round cuts, but 
not in top sirloin. This means that the difference between a high AA steak and one 
grading low AAA may be smaller than between low AAA and high AAA grades, yet 
premiums are often given for beef consistently grading AAA or higher (DiCostanzo and 
Dahlen, 2000). This may leave consumers confused about their perception of the AAA 
grade if they happen to purchase a steak on the low end, giving them more of an AA 
eating experience. There is a clear interplay between the quality grading of beef and 
consumer purchasing decisions based upon their eating experiences. This interplay 
should have a major influence on the beef market for profits to increase.  
 A study by Platter et al. (2005) found that consumers were more likely to prefer 
steaks with shear force measurements associated with increased tenderness, as well as 
higher quality graded (the equivalent of mid-Canada AAA or higher) beef. Aversion from 
buying tougher steaks (Warner-Bratzler shear force: WBSF; measure of > 3.9 kg), and 
those of lower quality grade (mid-AA or lower) were also observed. The researchers 
predicted that a minimum quality grade of mid-Canada AA and a maximum WBSF 
measurement of 3.9 kg were the baselines above which most beef consumers would 
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attempt to buy a steak. In a bidding scenario, consumers offered to pay on average 
$0.89/kg more for steaks graded in the upper half of Canada AAA, and $2.47/kg more for 
Prime steaks (Platter et al., 2005). With respect to tenderness, a decrease in consumer-
valued price of $1.02/kg was predicted for every 1 kg increase in WBSF measurement 
(Platter et al., 2005).  
 Froehlich et al. (2009) also found that consumers were willing to pay more for 
Canada AAA steaks, and those guaranteed to be tender. They suggest that by providing 
beef of guaranteed higher eating quality to knowledgeable consumers, through labeling or 
branding, the industry could increase the value of beef in this country. Therefore, both the 
Platter et al. (2005) and Froehlich et al. (2009) studies show that consumer demand, as 
well as value for the product can be bolstered by improvement upon the quality of beef 
being produced and offered in the marketplace.  
 The marketing and pricing of cattle is variable between producers, markets, and 
over time. They can be priced on a live weight, dressed weight, or grid or formula pricing 
system, and often alliances or agreements are made between feedlots and packing plants. 
These agreements involve decisions with respect to base price and premiums or discounts 
received for certain carcass traits (DiCostanzo and Dahlen, 2000).  
 Cattle can be marketed towards many different consumer bases, as distinctive 
purchaser groups have different preferences (i.e. well-marbled, lean, hormone-free, 
organically raised; Feuz, 1999). The end result of marketing beef could vary greatly 
depending on pricing system and time. By developing grids based on the market to be 
targeted (based on buyer preferences), and through the production of cattle to better fit 
those grids, increased profits could be made as consumer experiences improve (Feuz, 
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1999). Developing an effective farm-to-retail supply chain has been suggested (Froehlich 
et al., 2009) with marketing strategies to brand a product benefiting all parties involved.   
 
2.4. Marker-Assisted Management Strategies 
Marker-assisted management (MAM) is the strategy of altering the way an animal is 
managed (i.e. raised/fed/bred) once the animal’s genetic information has been taken into 
consideration. This change in management is aimed towards increasing efficiency and/or 
the quality of the final product through improving upon a trait that is affected by specific 
genes. This MAM strategy is an offshoot of marker-assisted selection, which is the 
strategy of changing how animals are bred based on genetic information in order to 
improve upon a trait in future generations. Management strategies that may be altered 
include: the sorting of pens based on genotype to either feed different diets or for 
differing amounts of time; the use of implants or B-agonists in certain animals; or 
targeting certain animals for different markets to improve profits (Van Eenennaam and 
Drake, 2012). 
 Genetic variations between individuals that are associated with a difference in a 
phenotypic trait of interest are called DNA markers (Van Eenennaam et al., 2007). Some 
traits, referred to as simple traits, are more easily explained and predicted as they are 
controlled by only one gene with an associated marker allele. Multiple genes and the 
environment control other traits, known as complex traits, as they are often associated 
with multiple marker alleles. These complex traits are more difficult to predict and 
explain, but are the category under which many beef cattle production and carcass traits 
fall (Thompson et al., 2014).  
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 A MAM strategy currently employed commercially uses a single nucleotide 
polymorphism (SNP) in the leptin gene (Buchanan et al., 2002).  This LEPc.73C>T SNP 
is used to select animals by genotype to sort and manage them differently, as TT animals 
achieve a higher degree of marbling in the final carcass earlier than CC animals 
(Buchanan et al., 2007). This MAM strategy can significantly increase the profit for 
producers, both through breeding and management decisions. Testing for this leptin SNP 
is currently marketed for feedlot use by Quantum Genetics (Saskatoon, SK, Canada). The 
effect of the SNP is somewhat lessened when Zilpaterol Hydrochloride is fed (Kononoff 
et al., 2013), therefore this type of MAM may not be ideal in all feedlot management 
strategies (Van Eenennaam and Drake, 2012). 
 Van Eenennam and Drake (2012) suggest that the greatest value of DNA testing in 
MAM lies in the breeding sector, but it may be more feasible at the feedlot level as the 
cost of testing lessens with increased numbers. The authors determine that so long as 
good accuracy exists for the tested markers at predicting valuable feedlot traits, and that 
incentives are offered up the beef production chain to have animals tested, MAM could 
be a valuable strategy in feedlots. Consistently well-marbled carcasses may receive 
premiums, and in previous studies (Ward et al., 2012; Krone et al., 2016) the TT 
ADH1Cc.-64T>C genotype has been shown to increase IMF when VA is limited in 
finishing rations – giving it great potential as a feedlot MAM strategy to increase profits.  
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3. HYPOTHESES 
Previous research suggests that beef cattle marbling could be improved by restricting 
dietary VA and that the ADH1C X VA MAM strategy improves IMF when TT animals 
are fed limited VA. Growth promotants are known to improve production and yield 
characteristics, while hindering fat traits. Clinically relevant VA deficiency symptoms 
often only occur after a severe limitation of dietary VA in beef cattle. Given these 
previous findings, my hypotheses were as follows: 
 
1) Animals with lower VA levels in their diet will have increased marbling scores. In this 
case, animals fed the test level of VA (50% of NRC) will show improved fat 
characteristics when compared to animals consuming the 100% NRC level (2200 IU/kg; 
NRC 1996).  
2) Animals with the TT genotype at ADH1Cc.-64T>C will show increased marbling 
scores when compared to CT animals, when VA is fed at 50% of NRC. 
3) Implanted animals will show reduced fat traits (including marbling scores) when 
compared to non-implanted animals. 
4) The highest amount of marbling will be seen in TT animals, fed 50% NRC, that were 
non-implanted. The second highest will be TT, 50% NRC animals, with implants. This 
would prove the efficiency of using the ADH1C SNP in MAM practices at a commercial 
level. 
5) Animals with reduced 25% and 75% NRC levels of dietary VA will not show any 
form of diagnosable indicators of decreased immune function or symptoms of VA 
deficiency. 
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4. A FEEDLOT TRIAL REDUCING VITAMIN A IN COMBINATION WITH 
ADH1C GENOTYPE TO IMPROVE INTRAMUSCULAR FAT 
4.1. Abstract 
A previously discovered variant in the ADH1C gene has been shown to improve 
intramuscular fat in beef cattle when dietary vitamin A (VA) was limiting. This 
ADH1Cc.-64T>C single nucleotide polymorphism (SNP) has the potential, through a 
marker-assisted management (MAM) strategy, to increase profits for producers, and 
therefore it needed to be tested at a commercial level. Two thousand mixed breed beef 
steers were separated into 40 feedlot pens depending on genotype (TT or CT). Half of the 
pens were implanted, the other half were not. Treatments of 50 or 100% levels of the 
NRC (1996) recommendation of dietary VA were randomly assigned so an equal number 
of treatment combinations were achieved. Steers were sent to slaughter when the pen 
average weight reached 612 kilograms, and production and carcass data were collected. 
The expected VA X ADH1C effect was not observed for any trait in either the implanted 
(IMP) or non-implanted (NI) animals, however implant status did significantly affect Dry 
Matter Intake (IMP = 8.55. ± 0.113 kg; NI = 7.87. ± 0.113 kg; P < 0.01), Total Days-on-
Feed (IMP = 164.40 ± 2.782 days; NI = 210.45 ± 2.782 days; P < 0.01), USDA Yield 
Grade (IMP = 2.40 ± 0.046; NI = 2.77 ± 0.046; P < 0.01), Marbling Score (IMP = 391.90 
± 4.193; NI = 454.90 ± 4.193; P < 0.01), Rib-Eye Area (IMP = 84.97 ± 1.135; NI = 80.65 
± 1.135 cm2; P = 0.01), and Backfat Thickness (IMP = 8.07 ± 0.281 mm; NI = 10.01 ± 
0.281 mm; P < 0.01). Average Daily Gain was affected by implant status in combination 
with ADH1C genotype, however the genotype effect may be a type I error. No other main 
effects of VA or ADH1C genotype were observed, suggesting along with a lack in their 
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interaction effects, that this MAM strategy is likely not viable at a commercial level. The 
findings related to implant status effects support previous literature. The significant 
effects of the hormonal implants also continue to emphasize their profound benefits in 
improvements in production traits and yield, but also their deficits, such as reductions in 
marbling scores and other fat traits. 
 
Implications  
The marker-assisted management strategy utilizing ADH1C and limiting vitamin A in 
finishing rations is not yet ready for application at a commercial level. The expected 
effects on fat traits were not observed.  This may have been due to insufficient time on 
the 50% level of recommended vitamin A in the diet. In this study, hormone implants had 
a strong effect on production and carcass traits, suggesting major benefits, but also some 
drawbacks to their use. With premiums being possible for consistently well-marbled beef, 
the negative effects of implants on fat traits should be considered. 
 
4.2. Introduction 
The competitive beef cattle industry is constantly looking for ways to produce more 
valuable beef in an efficient manner. Marker-assisted management (MAM) is a strategy 
used to achieve this. It is a process by which genotypic information of an animal is used 
to facilitate management decisions in order to improve the end product. Prior nutrigenetic 
studies have shown that a single nucleotide polymorphism (SNP) in the alcohol 
dehydrogenase 1C (ADH1C) gene, ADH1Cc.-64T>C, when combined with limiting 
dietary vitamin A (VA), significantly increases intramuscular fat (IMF) deposition in beef 
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steers (Ward et al., 2012; Krone et al., 2016). Separating TT animals at this SNP, and 
feeding them reduced dietary VA has been suggested as a possible MAM strategy to 
improve marbling for feedlots moving forward, however testing at a commercial level 
was still required. 
 Adipogenesis is one of the many bodily functions in which VA plays an important 
role. Ingested in a carotenoid form, VA is stored primarily in the liver. When mobilized 
from the liver, now retinol (ROL) binds to retinol binding proteins to circulate within the 
blood (Blomhoff, 1990; Quadro et al., 2003). The enzyme ADH1C converts ROL to 
retinaldehyde (RAL) and this reaction can also function in the opposing direction. 
Another enzyme, RALDH, can then further oxidize RAL to retinoic acid (RA; Duester, 
2000). Retinaldehyde is known to have a negative impact on fat deposition (Ziouzenkova 
et al., 2007), while RA can bind to the retinoic acid receptor (RAR) and the retinoid X 
receptor (RXR), which then are able to dimerize and interact with retinoic acid response 
elements (RAREs) within genes involved in apdiogenesis to affect their expression 
(Heyman et al., 1992; Zhang et al., 1992; Ziouzenkova et al., 2007). This altering of 
expression primarily encourages fat deposition, which leads to an opposing effect of RAL 
and RA on adipogenesis.  
 The SNP discovered in ADH1C by Ward et al. (2012) is thought to remove a 
CCAAT/enhancer binding protein α binding site when the C allele is present, which leads 
to decreased ADH1C expression in CC compared to TT animals. This decrease in 
expression of the ADH1C gene (Ward et al., 2012) and the subsequent decrease in the 
amount of ADH1C protein present in the liver (Krone et al., 2016) are thought to account 
for a decreased conversion of ROL to RAL. This decreased conversion would also 
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decrease the amount of RA produced that would normally have a positive impact on 
marbling. 
A dietary inclusion level of 2200 IU/kg dry matter (DM) per day is recommended 
by the National Research Council (NRC, 1996) as the requirement for VA in feedlot 
rations. This level is often surpassed in feedlots, with no negative health effects; however, 
VA in excess impedes marbling as RAL decreases fat deposition (Kawada et al., 2000; 
Ziouzenkova et al., 2007). Limiting dietary VA in order to improve marbling has been 
researched extensively, with mixed results. Significant improvements in fat traits were 
observed in some research where VA was limited (Oka et al., 1998; Wang et al., 2007; 
Kruk et al., 2008; Gibb et al., 2011; Pickworth et al., 2012a), while others (Gorocica-
Buenfil et al., 2008; Bryant et al., 2010) found no significant effects of altering the 
dietary level. Through grid marketing programs, consistently high marbling grades can 
lead to premiums being paid to producers (DiCostanzo and Dahlen, 2000), therefore the 
study of VA restriction leading to improved fat traits is highly relevant to today’s beef 
market. 
It is common practice in North America to use hormonal implants or other growth 
promotants in commercial beef production. While having a primary purpose of improving 
lean meat yield and decreasing finishing time in feedlots, hormone implants have been 
shown to significantly: increase average daily gain (ADG), dry matter intake (DMI), and 
rib-eye area (REA); and improve gain to feed ratios in feedlot steers (Foutz et al., 1997; 
Wileman et al., 2009). Foutz et al. (1997) also found that implants tended to be 
associated with decreased marbling scores, yield grades (however decreased yield grades 
signify improved yield with a score of 1 being optimal), and increased shear force values.  
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The objective of this study was to determine whether feeding an intermediate 
level of VA to animals TT at the ADH1Cc.-64T>C SNP in a commercial feedlot setting 
would improve marbling. We hypothesized that the impact of hormone implants would 
negatively impact marbling, and that animals CT at ADH1Cc.-64T>C as well as animals 
fed the NRC recommended level of VA would have lower marbling scores. 
4.3. Material and methods 
All animals were cared for according to the Guide to the Care and Use of Experimental 
Animals (Canadian Council on Animal Care, 1993) guidelines.  
Animals 
Mixed breed beef steers (N = 2960) were purchased at auction (averaging 274 kg) and 
transported to Cattleland Feedyards Limited (CFL). All animals were fed a commercially 
equivalent step-up diet upon arrival, with the diet being stepped-up every 5-7 days. They 
were held for a maximum of one month on a 73.11% barley (DM) diet until enough 
animals were accrued and genotyped. Once sorted (averaging 340 kg), the cattle were 
moved to an 86.80% barley finishing diet (Table 4.3.1.), where they were held until 
slaughter. Supplementation of VA was consistent for all pens at 30 000 IU/head/day 
before sorting as per typical feedlot protocol. The barley silage averaged 13 472 ± 1580 
IU VA/kg DM. Based on an average dry matter intake of 8 kg/head/day, all pens received 
8500 IU VA/head/day from the basal ration. Pens assigned the 100% NRC diet received 
an additional 9290 IU/head of VA supplement mixed in the feed, which equaled the 2200 
IU/kg DM recommended by NRC (1996).  The 50% NRC pens received only the VA in 
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the basal diet, which equaled 1062.5 IU VA/kg DM (Table 4.3.1.). Representative silage 
samples were sent to DSM Nutritional Products Inc. (Ayr, ON) for β-carotene analysis 
using AOAC official method 974.29 and the DSM Nutritional Products Green Book 
(2004) as in Gibb et al. (2011). Beta-carotene was converted to VA using a conversion 
factor of 400 (NRC, 1970). Vitamin A supplement was adjusted accordingly. All pens 
received Rumensin® Premix with microtracer (Elanco, Guelph, ON) at 33.00 ppm, Tylan 
100 premix (Elanco, Guelph, ON) at 11.00 ppm, and 454.00 mg/head BioPowerLA 
Micro cell (Lallemond Animal Nutrition, Montreal, QC), as well as 2870 IU/head 
vitamin D and 150 IU/head vitamin E. Animals were sent for slaughter once the average 
weight of each pen reached approximately 612 kg. Sick animals were pulled from pens 
and treated on site in the feedlot clinic on up to three occasions before being removed 
from the study. Numbers of animals that were removed from their pens for treatment, 
pulled from the study, railed, or died were totaled for each pen and were analyzed 
statistically as a proportion of animals per pen. 
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Table 4.3.1. Diet composition and nutrient analysis of low and high vitamin A (VA) finishing 
rations on a dry-matter basis 
Low VA High VA 
Diet composition, % DM 
Rolled barley 86.80 86.80 
MICRO 0.66 0.66 
CFY DFS C05430 2.01 2.01 
Molasses 2.68 2.68 
Barley silage 7.85 7.85 
Nutrient analysis, % DM 
Total digestible nutrients 81.50 81.50 
Crude protein 13.00 12.90 
Acid detergent fiber 8.60 8.50 
Neutral detergent fiber 15.40 16.10 
Ca 0.53 0.60 
P 0.42 0.41 
Dietary VA (IU/kg DM) 1062.5 2223.9 
VA = Vitamin A; DM = Dry Matter; IU = International Units 
 Genotyping and Sorting into Treatment Groups 
Using the ear tissue tagging system and DNA extraction method at Quantum Genetix 
(Saskatoon, SK), DNA from each animal was obtained. A polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) test for the ADH1C SNP (Ward 
et al., 2012; Krone et al., 2016) was then run, and 2000 animals were randomly selected 
and sorted at CFL into pens of 50 animals each, based on genotype (either TT or CT; 
Figure 4.3.1.). Half of the pens were implanted (IMP) with Component TE100 (Elanco, 
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Guelph, ON) at sorting, and again at 70 days after the first implant. Pens were assigned to 
either 50% or 100% of NRC VA requirement, therefore there were 5 pens each of: CT 
genotype, IMP, 50% VA; CT, IMP, 100%; CT, non-implanted (NI), 50%; CT, NI, 100%; 
TT, IMP, 50%; TT, IMP, 100%; TT, NI, 50%; and TT, NI, 100%. Vitamin A supplement 
was mixed in with the daily ration and hence pen was the statistical unit.  
The 2000 cattle selected for the trial were also genotyped at the MC1R SNP 
(Klungland et al., 1995) to determine coat colour, as black or not black. Previous studies 
researching this nutrigenetic interaction between the ADH1C genotype and VA level 
involved only black animals while this trial included steers of any colour. 
Figure 4.3.1. Diagram demonstrating how steers were sorted into different treatment pens based 
on ADH1Cc.-64T>C genotype. Implants and vitamin A treatments (percentage of NRC, 1996 
recommendations) were then also applied accordingly. The red cell depicts the group of animals 
that would follow the same pattern as shown for the TT animals, but would have the CT genotype. 
The end result is 40 pens in total, made up of an equal number (n = 5) of every treatment 
combination. 
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Production Data 
Steers were weighed at the time of sorting, at 70 days post-sorting when implanted 
animals were re-implanted, and at shipping. Average daily gain (ADG, kg per day) values 
were calculated as the difference in weights divided by the number of days between the 
two measurements. Dry matter intake (DMI) data was obtained from CFL, where the 
cattle were provided feed ad libitum intake once daily, and the amount of feed provided 
per pen was recorded daily. Bi-weekly ration samples were collected, and DMI values 
were confirmed by a nutritionist. Total days-on-feed (TOTDOF) is the number of days 
from start of trial until slaughter. 
Carcass Data 
Carcass data (USDA Yield Grade, VGUSYLD, scale from 1.0-5.9; Marbling Score, 
VGMARB, scale from 200-900; Rib-eye Area, REA, square centimeters; Fat Thickness, 
FAT, mm) was obtained for each animal from JBS Food Canada (Brooks, AB) where the 
animals were slaughtered. A VBG 2000 e+v Technology GmbH vision camera grading 
system was used to obtain the VGUSYLD, VGMARB, REA, and FAT data.  
Statistical Analysis  
The mixed model procedure of SAS 9.4 (SAS Version 9.4; SAS Institute, Inc., Cary, NC, 
USA) was used to analyze data for the two genotypes (TT or CT), by two VA treatments 
(50% or 100%), by two implant status treatments (IMS or NI; IMS) factorial design. The 
experimental unit in this study was the pen. Standard errors were adjusted using a 
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Kenward Roger adjustment and means were separated using Tukey’s LSD. Significance 
was set at P ≤ 0.05 and trends at 0.05 > P ≤ 0.10. 
 
4.4. Results and discussion 
Animals 
There were no significant differences between treatment of sick animals or mortality with 
ADH1C genotype, VA, or IMS (data not shown). There were also no interaction effects 
between these variables on animal health. As VA also impacts immune function, this 
measure was important to assess any negative effect that this MAM strategy could have 
had on animal health. 
  
Genotyping 
 
Genotyping at the ADH1Cc.-64T>C SNP was conducted on 2960 British crossbred beef 
steers to select 2000 animals for the feeding trial. The minor allele (C) frequency in this 
population was 0.26, compared to 0.3 in the Ward et al. (2012) study.  Genotyping the 
entire population of steers only yielded 970 CT animals, therefore the CT pens had to be 
supplemented with 30 CC animals. These two genotypes do not differ significantly with 
respect to carcass or production data (Ward et al., 2012; Krone et al., 2016). The minor 
allele (C) frequency is 0.3 (Ward et al., 2012), which made it difficult to select for a large 
number of CC animals. Since there is no significant difference between CC and CT, they 
were not included in the study as a separate genotype variable. The following number of 
animals finished the trial: 978 TT and 974 CT, including the 30 CC. Genotyping at the 
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MC1R SNP in the NI animals led to allele frequencies of T = 0.80 and C = 0.20, where 
276 were black and 639 were not. 
Production Data 
The only significant interaction effect observed was that between ADH1C and IMS on 
ADG (P = 0.03; Figure 4.4.1.). In implanted steers, CT animals had a significantly 
increased ADG (3.92%) over TT, while both were higher (28.98% and 24.12% 
respectively) than NI animals. An increase in ADG would be of benefit to producers as it 
would mean they could finish their animals sooner, save on production costs, and reduce 
the risks of keeping animals in the feedlot longer than necessary. The increase observed 
between IMP and NI animals was expected, as the use of implants increases lean meat 
yield while decreasing the feeding period. The significant difference between CT and TT 
genotypes within IMP animals was unexpected, and may in fact be coincidental. The 
significant difference in ADG has not been previously reported (Ward et al., 2012; Krone 
et al., 2016), but prior nutrigenetic work on the ADH1C and VA interaction used only NI 
animals. In these earlier studies by Ward et al. (2012) and Krone et al. (2016), the leaner 
of the two genotypes had in fact been the CT animals, so it may be possible for CT 
animals, when implanted, to also have a higher ADG. More research would be necessary 
before much weight is placed on its applicable significance. 
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Figure 4.4.1. A column graph representing the significant interaction effect of ADH1Cc.-64T>C 
genotype and implant status (IMP = implanted; NI = non-implanted) on Average Daily Gain. 
Each column symbolizes the mean of 10 pens. Differing letters on the figures represent 
significantly different values. Significance is considered as P ≤ 0.05.  
 
 Two production traits, namely DMI and TOTDOF, were significantly affected by 
IMS (Table 4.4.1.). Implanted animals had an 8.69% increase in DMI (Figure 4.4.2.a) and 
required 46 fewer days on feed compared to NI animals (Table 4.4.1.). While a lower 
DMI combined with equivalent or increased ADG would be beneficial at a production 
level, a slight increase in DMI for IMP animals that build lean meat yield quite quickly, 
would be expected. The decrease in TOTDOF for IMP animals is expected as they finish 
faster, which highlights again that the intended benefits to be drawn from implanting 
animals are in fact being achieved. It is beneficial at the feedlot level to send animals to 
slaughter as quickly as possible because management costs, stress, and disease challenge 
are all major economic and animal welfare factors.  
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Table 4.4.1. Production and camera grading carcass trait means separated by implant status. 
IMS mean P-value 
Variable IMP NI SEM IMS 
DMI 8.55 7.87 0.113       <0.01 
TOTDOF 164.40 210.45 2.782 <0.01 
VGUSYLD 2.40 2.77 0.046 <0.01 
VGMARB 391.90 454.90 4.193 <0.01 
REA 84.97 80.65 1.135   0.01 
FAT 8.07 10.01 0.281 <0.01 
IMS = Implant Status; IMP = Implanted; NI = Non-implanted; DMI = Dry matter intake (kg); 
TOTDOF = Total days-on-feed; VGUSYLD = Vision grade USDA yield grade; VGMARB = 
Vision grade marbling score; REA = Rib-eye area (sq cm); FAT = Fat thickness measurement 
(mm) 
Carcass Data 
Significant main effects of IMS were observed for VGUSYLD, VGMARB, REA, and 
FAT (Table 4.4.1.). Implanted animals had a 15.23% decrease in VGUSYLD scores (P < 
0.01; Figure 4.4.2.b), where a lower score is preferable, and a 5.37% increase in REA (P 
= 0.01; Figure 4.4.2.d). Beef animals with VGUSYLD scores that are too high are often 
discounted; while animals with larger REA are often valued higher as it is an indicator of 
meat yield. It would be typical of IMP animals to have increased REA and decreased 
VGUSYLD scores as they are implanted with growth promotants, and therefore targeted 
specifically towards a lean meat yield market. There is a negative correlation between 
REA and yield scores, while yield score is positively correlated with fat thickness 
(Kauffman et al., 1975).  
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Conversely, NI animals displayed significantly higher values for fat traits when 
compared to IMP steers (Table 4.4.1.). A 16.08% increase was observed for VGMARB 
scores (P < 0.01; Figure 4.4.2.c) and a 24.15% increase for FAT measurements (P < 0.01; 
Figure 4.4.2.e) of NI compared to IMP animals. Premiums are given to carcasses 
consistently high in marbling and of higher quality grades (DiCostanzo and Dahlen, 
2000). When marketing on a marbling grid specifically, much higher profits can be 
achieved through consistently high IMF (Feuz, 1999). Marbling is beneficial for flavor 
and eating experience (Killinger et al., 2004), but any increase in fat thickness is only 
acceptable up to a point, as too much backfat leads to increased yield grades, and 
discounted prices. The significant difference between IMP and NI animals for VGMARB 
scores is equivalent to an improvement from slight (Canada AA/USDA Select) to small 
(Canada AAA/USDA Choice) steak marbling grades, which would lead to increased 
prices for the NI steaks. There is however, a trade-off between marbling and yield, and 
therefore it makes sense for NI animals to be better marbled, while IMP animals are 
higher yielding. A reduction in total fatty acid percentage has been observed in IMP 
animals, although this finding seems to be due to a dilution of IMF as REA increases 
(Duckett et al., 1999). 
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Table 4.4.2. Effect of vitamin A treatment, ADH1Cc.-64T>C genotype, implant status, and their 
interactions on production and camera grading carcass traits. Bolded P-values indicate 
significance while italics indicate a trend. Significance is declared at P < 0.05, trends at P < 
0.10. 
Variable DMI 
(kg/day) 
TOT 
-DOF
ADG 
(kg/day) 
VGUS 
-YLD
VG 
-MARB
REA 
(sq cm) 
FAT 
(mm) 
ADH1C*IMS*VA 0.12 0.51 0.38 0.69 0.60 0.70 0.51 
ADH1C*IMS 0.54 0.60 0.03 0.51 0.68 0.97 0.37 
ADH1C*VA 0.54 0.62 0.64 0.88 0.60 0.85 0.96 
IMS*VA 0.48 0.41 0.06 0.90 0.31 0.55 0.45 
ADH1C 0.56 0.98 0.39 0.36 0.77 0.39 0.55 
IMS <0.01 <0.01 <0.01 <0.01 <0.01 0.01 <0.01 
VA 0.26 0.80 0.40 0.92 0.84 0.94 0.86 
DMI = Dry Matter Intake; TOTDOF = Total Days-On-Feed; ADG = Average Daily Gain; 
VGUSYLD = USDA Yield Grade; VGMARB = Marbling Score; REA = Rib-Eye Area; FAT = 
Fat thickness measurement; ADH1C= ADH1Cc.-64T>C genotype; IMS= Implant Status; VA= 
Vitamin A level 
Effectiveness of VA X ADH1C MAM Strategy  
In this nutrigenomic feedlot trial, we have primarily found that there was no ADH1C x 
VA treatment interaction effect on fat traits as previously shown by Ward et al. (2012) 
and Krone et al. (2016). No main effects of either ADH1C genotype or VA level were 
observed either (Table 4.4.2.). As dietary VA level has been shown to affect marbling in 
multiple studies (Oka et al., 1998; Kruk et al., 2008; Pickworth et al., 2012a), we suggest 
that the low level of VA was either not low enough or potentially not sustained for a long 
enough period of time to show an effect on carcass traits. Other studies, with shorter 
periods of decreased VA diets (Gorocica-Buenfil et al., 2008; Bryant et al., 2010), have 
also shown no effect on carcass traits, however those with longer periods of feeding low 
VA in the diets (Pickworth et al., 2012b) have shown significant effects. Specifically, 
Kruk et al. (2008) found that feeding unsupplemented VA rations to Angus steers for 10 
months led to significant increases in ether extracted IMF, and a trend for increased 
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marbling scores. They suggested that if the reduced VA diets had been fed for longer, 
they may have achieved greater differences in marbling scores. Ward et al. (2012) did  
achieve significant differences between unsupplemented and supplemented animals for 
marbling scores and IMF measurements after feeding animals for just 8 months, however 
the first 3 months of backgrounding were on a VA deficient diet in order to deplete liver 
VA stores. This was a proof-of-concept approach, which is too drastic, and not feasible 
for implementation at the commercial level. The animals in our study were on low or 
high VA treatments for approximately 5.5 months for IMP and 7 months for NI.  It may 
be likely then, that VA stores within the 50% NRC animals did not reach low enough 
levels to see a significant difference in carcass traits.  
The delivery method of VA, along with dosage, may be another factor affecting 
the lack of VA effects in this trial. Both Ward et al. (2012) and Krone et al. (2016) fed a 
monthly dose of VA via an oral bolus, while the animals in this study were supplemented 
with VA through its addition to their daily rations in their feed bunks. As we could not be 
certain exactly how much VA each animal ingested each day, the pen of animals (to 
which the treatment was applied) was analyzed as the experimental unit. This daily dose 
in the feed as opposed to a monthly oral bolus however, may have altered the effect of 
limiting the animal’s dietary VA.  
Stress or the epigenetic effects of stressful conditions may also have played a role 
in how much of an effect dietary VA could have on cattle carcass traits. Curley (2004) 
found that more excitable temperaments in cattle led to significantly higher 
responsiveness to stress and higher basal glucocorticoid concentrations. Increased 
excitability has been significantly associated with higher serum cortisol concentrations as 
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well as reduced tenderness in beef cattle (King et al., 2006). Kruk et al. (2008) observed 
a drastic drop in plasma retinol in both treatment groups of animals during the final 12-
day period of the trial. During these 12 days, the animals finished their time at the 
feedlot, were shipped 1000 km to an abattoir, and processed. The steer populations in the 
Ward et al. (2012) and Krone et al. (2016) studies were both transported over 750 km to 
a processing facility, while the animals in the current study only had to travel 
approximately 130 km before slaughter. The two prior ADH1C x VA nutrigenetic studies 
also included frequent handling of the animals, where they were brought through the 
chute at least once per month for weighing, bolusing, or sampling. The animals in this 
study were allocated to treatment groups, weighed once about halfway through the trial, 
and were otherwise not removed from their pens unless being treated for injury or 
disease. These differences in handling and transport may have allowed for the Ward et al. 
(2012) and Krone et al. (2016) steers to be more prone to VA effects on carcass traits. 
Prior ADH1C x VA nutrigenetic studies only involved steers that were black in 
colour. This is because animals that are black in colour have at least one ED allele at 
MC1R, which is associated with significant increases in backfat and average fat when 
compared to red animals (McLean and Schmutz, 2009). No restrictions on breed or 
colour were placed on the animals in the current study, and therefore we considered that 
the ADH1C x VA interaction effect may only be applicable to black, or primarily Black 
Angus cattle. As the animals of the prior studies were also NI, the current NI steers were 
genotyped and analyses incorporating MC1R genotype were run (data not shown). Black, 
NI steers did not show the expected nutrigenetic interaction effect, so this possible theory 
can also likely be ruled out. The effect of VA restriction on marbling and IMF has been 
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demonstrated in Japanese Black (Oka et al., 1998) and Angus (Kruk et al., 2008) or 
Angus crossbred (Pickworth et al., 2012a; Pickworth et al., 2012b) cattle. As the animals 
in this study were mixed breed beef cattle, breed effect may have played a role in the 
absence of a significant effect of VA restriction. 
The steers in the current study were allocated to either be NI or IMP, while the 
previous nutrigenetic studies similar to this one used only NI animals. This could be a 
confounding factor, but further analyses (data not shown) where IMP and NI pens were 
separated did not show the expected interaction effect either. Additional main effects 
aside from IMS were also not significant in the results of our original statistical model, 
which would account for this, so this is also not a plausible explanation for our 
unexpected results.   
4.5. Conclusions 
The validation of the ADH1C x VA nutrigenetic approach in the commercial feedlot 
sector was the overall goal initially however; this study suggests it may not be a plausible 
MAM strategy at this stage. The lack of an ADH1C main effect was expected as none 
were observed by either Ward et al. (2012) or Krone et al. (2016), and Ward et al. (2012) 
concluded that limiting VA was required to also have a significant effect of the ADH1C 
genotype. The lack of significance of VA as a main effect was unexpected, however the 
limited length of time on decreased dietary VA may have confounded our results. 
Significant main effects of IMS on carcass traits VGUSYLD, VGMARB, REA, and FAT 
were expected, as were the effects on production traits ADG and TOTDOF due to the fact 
that the overall effect of hormonal implants is the building of lean meat reasonably 
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quickly. The effect of IMS on DMI is not as commonly reported in the literature, 
however it would make physiological sense that IMP animals would eat slightly more 
than NI animals in order to quickly build this lean yield.  
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5. ANALYSIS OF IMMUNE FUNCTION IN FINISHING BEEF STEERS FED
VARYING LEVELS OF VITAMIN A IN COMBINATION WITH DIFFERING 
ADH1C GENOTYPES 
5.1. Abstract 
A marker-assisted management strategy has been proposed that involves the ADH1Cc.-
64T>C single nucleotide polymorphism (SNP) combined with limiting dietary vitamin A 
(VA) in feedlot cattle to improve intramuscular fat and marbling traits. The degree to 
which dietary VA can be limited is not well understood and deficiency could lead to 
production and animal health consequences. Both of these consequences would result in 
losses for the producer. Of interest in feedlot animals are the consequences that limiting 
VA may have on immune function, as these animals may endure significant times of 
stress and disease challenge. Eighteen crossbred steers were sampled, with the ADH1C 
genotype (TT, CT, and CC) and VA level (25% or 75% of NRC, 1996 recommendations) 
equally represented. A complete blood cell count analysis, peripheral blood mononuclear 
cell proliferation and stimulation assay, and quantitative reverse-transcription polymerase 
chain reaction (qRT-PCR) analysis of cytokine expression was completed for each 
sample. The level of VA did not significantly affect any of the analyzed measures 
indicating immune responsiveness. A significant pen effect was observed for fibrinogen 
concentration in whole blood, however the values for this measure did not fall outside of 
the reference range. A significant genotype effect was observed on IL-4 expression, 
where CC animals had significantly lower expression levels than CT and TT animals. As 
CC animals did not have any other observable signs of VA deficiency or impaired 
immunity, we assume that this finding may speak more to the relationship between 
retinoids (and their effector enzymes – ADH1C) and lymphocytes than to deficiency 
47 
concerns. Previous research has suggested that a severe level of VA limitation would be 
required to diminish immune function and our research supports this.  
Implications  
A mutation in the ADH1C gene has been shown to improve fat traits when vitamin A is 
limited in beef cattle. Restricting vitamin A could lead to impairment of immune 
responsiveness due to deficiency, so the immune effects of this management strategy 
needed to be tested.  No significant differences were found between diets of 25% and 
75% of the vitamin A recommendations. Two significant effects were observed, however 
they were either not biologically significant, or did not coincide with other deficiency 
markers. Feeding 25% of the recommended level of vitamin A did not result in 
immunological deficiencies in this study.  
5.2. Introduction 
Cattle in North American feedlots today often receive more than the required 2200 IU/kg 
dry matter (NRC, 1996) of vitamin A (VA). It is suggested that higher dietary levels of 
VA have the potential to impede fat deposition (Kawada et al., 1996; Ohyama et al., 
1998; Kawada et al., 2000; Ziouzenkova et al., 2007). For beef cattle, a decrease in fat 
deposition or marbling potential could result in reduced profits for producers. Limiting 
dietary VA has therefore become a strategy attempted in research studies with results 
being: significantly increased intramuscular fat (IMF), a negative correlation between 
serum retinol (ROL) and marbling scores, and numerically increased marbling scores 
(Kruk et al., 2008); and significantly increased quality grades and a trend towards 
increased IMF (Pickworth et al., 2012) in Angus and Angus crossbred steers respectively. 
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Wagyu cattle have shown an increase in marbling with decreased VA intake (Oka et al., 
1998) as well.  
Nutrigenetic studies looking at a thymine to cytosine substitution in the promoter 
region of the alcohol dehydrogenase 1C gene (ADH1C; Ward et al., 2012; Krone et al., 
2016) found that crossbred beef steers TT at the ADH1C c.-64T>C single nucleotide 
polymorphism (SNP) had significantly increased IMF when dietary VA was reduced, 
when compared to other genotypes and other levels of VA. This ADH1C c.-64T>C SNP 
removes a binding site for the transcription factor CCAAT/enhancer-binding protein α, 
and therefore reduces the expression of the ADH1C protein (Ward et al., 2012). The 
ADH1C protein is responsible for the oxidization of ROL to retinaldehyde (RAL), which 
can be oxidized by RALDH to retinoic acid (RA; Duester, 2000). The activity of the 
ADH enzyme is known to increase threefold when VA is deficient (Napoli, 1996), likely 
depleting RAL if it is limiting. Retinaldehyde is known to inhibit fat deposition 
(Ziouzenkova et al., 2007), and RA is thought to stimulate fat deposition through its 
binding to retinoic acid response elements in the promoter regions of genes (Heyman et 
al., 1992; Gregoire et al., 1998). Having a TT genotype at ADH1C (normal levels of the 
circulating ADH1C protein) would allow for enough ROL to be converted to RAL for 
ADH to then convert it to RA. This conversion would then improve IMF deposition both 
from depleting the available RAL, and increasing levels of RA (Ward et al., 2012). At a 
feedlot level, increases in IMF, and consistent improvements in marbling scores could 
mean increased profits for producers. 
Increasing profits by limiting dietary VA in feedlot cattle, depending on genotype, 
could be an effective marker-assisted management (MAM) strategy. Vitamin A also 
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plays a significant role in the immune system, which is a system of critical importance for 
these animals during times of repeated stress and disease challenge. Sending feedlot 
animals into VA deficiency could be disastrous. Inefficiencies in production traits, 
weakness, and reproductive issues tend to be the earlier symptoms of the deficiency, 
while ataxia, blindness, xerophthalmia, convulsions, and syncope may occur at later 
stages (Hill et al., 2009). As VA deficiency decreases the efficacy of immune function, 
and disease can reduce VA uptake and absorption, as well as increasing its excretion 
(Stephensen, 2001), this cyclic relationship could greatly harm feedlot animal welfare.  
While improving profits for producers through a MAM strategy using the 
ADH1Cc.-64T>C SNP and limiting dietary VA is an economically beneficial endeavor, 
the wellbeing of the animals must be proven before this technology could be 
implemented at a commercial level. Should VA deficiency occur in a commercial feedlot, 
increased disease and mortality in feedlot animals could reduce profits substantially. In 
this study, we aimed to determine any adverse immunological effects that may arise in 
feedlot cattle, TT, CT, or CC at the ADH1C c.-64T>C SNP, fed 25 or 75% of the NRC 
(1996) recommended level of VA. We used clinical indicators for immune 
responsiveness from complete blood cell counts, peripheral blood mononuclear cell 
(PBMC) stimulation indexes (STIM), and real-time polymerase chain reaction (RT-PCR) 
results for the expression of important cytokines (IL-2, IL-4, IL-5, IL-10, and IFN-γ) in 
order to determine possible immune function deficiencies. We hypothesized that animals 
with reduced VA supplementation up to 25% of NRC (1996) recommendation would not 
show any form of diagnosable decreased immune function or symptoms of VA 
deficiency.  
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5.3. Material and methods 
All animals were cared for according to the Guide to the Care and Use of Experimental 
Animals (Canadian Council on Animal Care, 1993) guidelines. All experimental work 
involving animals was approved by the University of Saskatchewan Animal Care 
Committee. 
Animals 
Three animals of each ADH1C genotype (TT, CT, and CC) and VA level (25% and 75% 
NRC) were randomly selected, across genotype and VA level, from two intensive pens 
from a trial that occurred in Fall 2012-Summer 2013 (Krone et al., 2016) at the 
University of Saskatchewan’s Beef Cattle Research Facility. Initially, 450 black 
crossbred beef steers were genotyped at the ADH1C SNP locus through the use of a tail 
hair sample, DNA extraction procedure, and a PCR-RFLP test (see Krone et al., 2016). 
These 450 animals were then randomly selected from to reach a study population 
consisting of 45, 45, and 27 animals of TT, CT, and CC genotypes respectively, that were 
fed either 25%, 50%, or 75% of NRC recommendations for VA. These VA levels were 
achieved using a monthly oral gelatin bolus (Torpac Inc., Fairfield, NJ, USA) filled with 
sugar and the appropriate monthly dose of VA in the form of retinyl palmitate (1,000,000 
IU/g, Adisseo, Antony, France). Daily fed rations were unsupplemented for VA, and their 
naturally occurring level of VA was used to calculate the appropriate inclusion level of 
VA in the monthly boluses (as in Krone et al., 2016). All treatment information and 
disease events were recorded over the duration of the study. 
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Blood Cell Counts 
Blood samples (24 ml) were drawn from the subset of 18 animals from the jugular vein 
into vacutainers containing EDTA as an anticoagulant. These samples were taken two 
weeks before slaughter, and a 6 ml portion of the blood drawn from each animal was sent 
to Prairie Diagnostic Services (Saskatoon, SK) for complete blood cell count analysis. Of 
particular interest were the white blood cell (WBC; x 109/L), segmented cell (SEGS; x 
109/L), banded cell (BANDS; x 109/L), red blood cell (RBC; x 1012/L), total protein 
(TOTPROT; g/L), and fibrinogen (FIB; g/L) counts. 
Peripheral Blood Mononuclear Cell Isolation 
Another 18 ml portion of the blood sample from each animal was used for PBMC 
purification. Samples were separated by centrifugation at 2500 rpm (1350 g) for 20 
minutes at room temperature; buffy coats were then removed and suspended in 8 ml of 
PBSA containing 2.7 mM EDTA (PBSA/EDTA). Solutions were each transferred to 
Ficoll gradients (GE Healthcare, Uppsala, Sweden) and centrifuged at 3000 rpm (1940 g) 
for 20 minutes at room temperature. Peripheral blood mononuclear cells were removed 
from the interface between Ficoll and PBSA/EDTA, suspended in 8 ml of the 
PBSA/EDTA solution, and centrifuged at 1200 rpm (311 g) for 10 minutes at 4oC. 
Supernatant was removed, cells were resuspended in 10 ml PBSA/EDTA solution, and 
the centrifugation at 1200 rpm as well as the resuspension steps were repeated once more. 
The suspension was centrifuged one last time at 1000 rpm for 10 minutes at 4oC, and 
supernatant was removed. The PBMCs were resuspended in 4 ml Minimum Essential 
Media (MEM, Invitrogen Canada Inc., Burlington, ON) which contained 10% fetal 
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bovine serum, 50 μM 2-mercaptoethanol, 1% sodium pyruvate, 1% non-essential amino 
acids and 1% HEPES, with 50 μg/ml gentamycin added (MEM-plus). A Coulter counter 
was used to determine cell counts.  
PBMC Stimulation and Proliferation Assay 
A concentration of 3.5x106 cells/ml PBMC suspension was achieved by resuspending 
purified PBMCs in MEM-plus. A 100 μl volume of this suspension was added in 
duplicate to the wells of a 96 well tissue culture plate (Corning Inc., Corning, NY, USA). 
Cells were incubated at 37oC in 5% CO2 for 72 hours where one sample from each 
duplicate pair was incubated in the presence of 1 μg/ml concanavalin A (ConA; Sigma-
Aldrich, Oakville, Ontario, Canada). Twenty microliters of a 0.4 μCi/ml solution of 
tritiated thymidine (American Radiolabeled Chemicals, St. Louis, MO) was added to 
each well and plates were then incubated for an additional 18 hours. The incorporation of 
tritiated thymidine into cultured PBMC cells was determined using a liquid scintillation 
counter (TopCount NXT, Perkin Elmer Inc., Waltham, MA, USA). A stimulation index 
was calculated by dividing stimulated cell counts by those from unstimulated controls.   
Peripheral Blood Mononuclear Cell qRT-PCR 
As above, 100μl of a 3.5x106 cells/ml PBMC suspension was allocated to 96 well tissue 
culture plates in duplicate and one well of each duplicate pair was stimulated with ConA 
but were separated for use for RNA isolation for qRT-PCR prior to the addition of 
tritiated thymidine. Extraction of RNA was achieved by using Trizol® reagent 
(Invitrogen Canada Inc., Burlington, ON) as described previously (Simms et al., 1993). 
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Extracted RNA samples were resuspended in 40 μl RNase-free water and quantified 
using a NanoDrop Lite Spectrophotometer (Thermo Scientific, Burlington, ON). 
Each isolated RNA sample had its concentration adjusted to 50 ng/μl and samples 
were prepared for RT-PCR using DNaseI (Invitrogen Canada Inc., Burlington, ON) as 
recommended by the manufacturer. Reverse-transcription PCR with 50 μM random 
hexamer primers and SuperScript™ II reverse transcriptase (Invitrogen Canada Inc., 
Burlington, ON) was used to complete reverse transcription. The PCR reaction was 
carried out using a T100™ Thermal Cycler (Bio-Rad Laboratories, Ltd., Mississauga, 
ON) according to SuperScript™ manufacturer recommendations with samples held at 
25oC for 10 minutes, 42oC for 50 minutes, and 70oC for 15 minutes.  
Quantitative real-time PCR was performed using SYBR™ Green (Invitrogen 
Canada Inc., Burlington, ON) on a Stratagene Mx3005P qPCR system (Agilent 
Genomics, Santa Clara, CA, USA) according to the manufacturer’s protocol. The qPCR 
cycles were as follows: 2 minutes at 95oC; 2 minutes at 95oC, 30 seconds at 60oC (1 
endpoint to take fluorescence reading), and 30 seconds at 76oC with this cycle run 45 
times; 30 seconds at 95oC; 30 seconds at 45oC; 30 seconds at 95oC; and a hold at 25oC 
before storing at -20oC. This cycle was followed in accordance with previous research 
featuring these primer sets (Table 5.3.1.), with the exception of an additional plateau at 81
oC (with 1 endpoint to take fluorescence reading instead of at 60oC) after each 76oC step. 
This was to remove any fluorescence read from the primer dimer dissociation curve peak 
observed with the IL-4 primer set. The qRT-PCR analysis was performed in duplicate and 
included the housekeeping gene β-actin. Specific primers for sense and anti-sense strands 
of β-actin, IL-2, IL-4, IL-5, IL-10, and IFN-γ genes were designed based on previous 
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work (Table 5.3.1.). Quantitative RT-PCR products were run on a 1% agarose gel, 
visualized, sequenced, and compared to reference sequences to ensure that the 
appropriate product was generated. Relative gene expression was calculated by 
normalizing cytokine expression to β-actin expression and comparison with untreated 
controls using the comparative threshold cycle (ΔΔCt) method. Relative expression data 
was analyzed using the 2-(ΔΔCt) method as described previously (Livak and Schmittgen, 
2001).  
Table 5.3.1. Primers used to amplify cytokine and housekeeping gene mRNA transcripts. Primer 
sequence, product length, and reference number (or source) are reported. 
Gene Primer 
direction 
Primer sequence Product 
length 
(bp) 
NCBI 
accession 
number/ 
reference 
Β-actin Forward 5’-AGGCATCCTGACCCTCAAGTA-3’ 95 AY141970 
Reverse 5’-GCTCGTTGTAGAAGGTGTGGT-3’ 
IL-2 Forward 5’-CCTCAACTCCTGCCACAATGTA-3’ 376 * 
Reverse 5’-GTTTGCAACGAGTGCAAGAGTTA-3’ 
IL-4 Forward 5’-ACGCTGAACATCCTCACAAC-3’ 125 ** 
Reverse 5’-CGCCTAAGCTCAATTCCAAC-3’ 
IL-5 Forward 5’-TGGTGGCAGAGACCTTGACA-3’ 320 * 
Reverse 5’-GAATCATCAAGTTCCCATCACCTA-3’ 
IL-10 Forward 5’-GATGCCACAGGCTGAGAACC-3’ 53 U11421 
Reverse 5’-GCGAGTTCACGTGCTCCTTG-3’ 
IFN-γ Forward 5’-TCCAGCGCAAAGCCATCAATGAAC-3’ 105 *** 
Reverse 5’-TCCGGCCTCGAAAGAGATTCTGAC-3’ 
*From Coussens et al. (2004)
**From Whale et al. (2006)
*** From Luby (2010)
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Statistical Analysis  
All statistical analyses were performed using IBM SPSS Statistics Package version 23 
(SPSS, Chicago, IL). Histograms and data screening was performed using the Explore 
feature, and data was notably skewed. Group comparisons for VA level (25% vs. 75%) 
and PEN (pen 9 vs. pen 10) were presented graphically as box plots, and differences 
between groups were tested with the non-parametric Mann-Whitney U test. Group 
comparisons for ADH1C genotype (TT vs. CT vs. CC) were presented graphically as box 
plots, and their differences were tested with the non-parametric Kruskal-Wallis test. 
Results were considered statistically significant at P ≤ 0.05. 
5.4. Results and discussion 
Animals 
Only five animals out of the total 117 were given antibiotics to treat disease events during 
the Krone et al. (2016) trial. Fat and liver biopsies had been conducted on this population 
and two animals were treated within days of receiving the first liver biopsy, and two 
animals were treated within days of receiving their second liver biopsy. One animal was 
treated after both liver biopsies. The need for antibiotics may have been as a result of 
infection from these incisions. There was no pattern in the five treated animals with 
respect to VA supplementation level, or genotype. Regardless, the low number of animals 
treated does not allow us to draw conclusions of causation of low dietary VA level or 
ADH1C genotype, but does suggest that nearly all of the animals had enough immune 
responsiveness to not require any treatment during the trial.  
Blood Cell Counts 
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During a period of infection or inflammation, an increase in WBC, SEGS, BANDS, 
TOTPROT, and FIB counts would all be expected, while the RBC count may decrease in 
times of malnutrition. In VA deficient animals, natural killer cells have been shown to 
decrease in number (Semba, 1998; Stephensen, 2001). Cell counts for WBC, SEGS, 
BANDS, RBC, TOTPROT, and FIB were obtained and the band neutrophil (BANDS) 
counts have been excluded from further discussion as only two animals had scores that 
were not 0, where both scored just above the reference interval, and there were no 
significant statistical findings. The WBC reference interval reported (provided by PDS, 
Saskatoon, SK) at the time of testing was 4.51-12.1 (x 109 cells/L), and only one test 
animal fell out of that range at 13.4 (TT, 25% VA, Pen 10). As reference intervals 
constitute the 95% confidence range for animals that are examined as “normal” (ie. not 
ill), it is likely safe to say that the PEN effect on the WBC results (Table 5.4.1.) may be a 
statistical trend, but is not biologically significant, as all but one animal would have 
clinically been considered “normal” upon examination. The statistical significance of 
fibrinogen with a PEN effect (Table 5.4.1.; Figure 5.4.1.a) is also not biologically 
relevant, as the reference interval for fibrinogen is 1-7 g/L (personal communications 
with PDS, Saskatoon, SK), and our values ranged from 1-5. There may have been a slight 
immune challenge going through Pen 10 at the time of testing, however while these 
numbers may be increased, they are still within the reference interval, and therefore we 
consider them to be normal findings, not an indication of sickness. Five animals did fall 
outside of the confidence range for WBC, SEGS, BANDS, and RBC (data not shown), 
however only one animal (CC, 25% VA, Pen 10) scored outside of the confidence range 
for more than one measure (SEGS and BANDS). There was no consistent pattern 
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between genotype, VA level, or pen of these five animals, so it is believed that 
biologically, these are also insignificant findings.  
PBMC Isolation and Stimulation 
Peripheral blood mononuclear cells include all white blood cell types. During VA 
deficiency, there is a reduction of proper functioning of neutrophils, macrophages, and 
natural killer cells (Semba, 1998; Stephensen, 2001). No significant effects were 
observed for STIM values in our study population (Table 5.4.1.). As the STIM is 
calculated by dividing the number of stimulated cells by those that were unstimulated, the 
lack of significant results in this study would suggest that neither ADH1C genotype, VA 
level, nor PEN had an effect on the number of cells proliferating or their ability to 
respond to the mitogen stimulus. If immune responses had been compromised by any of 
these variables, we would have expected a hindrance in the ability of PBMC cells to 
proliferate when stimulated. 
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PBMC Proliferation and qRT-PCR 
A lack of VA appears to greatly affect the antibody-mediated immune response, with 
impaired function of T helper 2 cells, and to a lesser extent has an effect on the lysing 
ability of cytotoxic T cells of the cell-mediated immune response (Semba, 1998; 
Stephensen, 2001). A shift from a T helper 2 to a T helper 1 response has been 
hypothesized (Semba, 1998), which would lead to a decrease in IL-4, IL-5, and IL-10 and 
an increase in IFN-γ and IL-12 cytokines. The cytokines IL-2 and IL-10 are also thought 
to play essential roles in the production of CD4+CD25+ regulatory T cells (Malek et al., 
2002; Zheng et al., 2004), which may be important for T cell maturation and 
differentiation. Expression of the cytokines IL-2, IL-5, IL-10, and IFN-γ were not 
significantly affected by ADH1C genotype, VA level, or PEN. A significant effect of 
ADH1C genotype was observed on IL-4 expression (Table 5.4.1.; Figure 5.4.1.b), where 
CT and TT animals had significantly higher expression than CC animals. Because IL-4 is 
a Th2-associated cytokine and retinoids are likely important in the functioning of all 
lymphocytes, we can hypothesize that a reduced level of ADH1C protein present may be 
correlated to a decrease in IL-4 expression, potentially due to the availability of RAL 
converted from ROL. Overall, the CC animals generally did not display clinical signs of 
being unwell compared to any other group, and therefore it is unlikely this is a 
problematic effect of genotype on expression. 
5.5. Conclusions 
We were concerned that feeding VA at a level of half of NRC (1996) recommendations 
or below could negatively affect immune function, and therefore cause the potential 
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ADH1C x VA MAM strategy to be detrimental to animal welfare. In previous studies 
however, no difference has been observed in responses to vaccinations in calves fed 3300 
IU VA/kg DM versus 1100 IU VA/kg DM per day (Jee et al., 2013), or supplemented at 
0 IU VA/kg DM versus 2200 IU VA/kg DM per day (Gorocica-Buenfil et al., 2008). This 
would suggest that a very severe level of VA limitation would likely be required to 
induce deficiency to the point of clinical deficits in immune responses occurring. We 
observed no effect of VA on any trait that could suggest VA deficiency or any immune 
deficit complications. From our research, it seems that the ADH1C x VA MAM strategy 
at 25% of NRC (1996) recommendations or above would likely not affect immune 
function in a detrimental manner. The significant PEN effect seen in the FIB counts, and 
the trend of PEN on WBC counts were, as mentioned above, not clinically significant. 
The significant ADH1C effect on IL-4 expression was interesting, as it may suggest a link 
between the presence of the ADH1C protein and IL-4 expression, however it also did not 
equate to CC animals being less immunologically sound. Caution must also be taken in 
interpreting these results, as the dosage of VA was orally administered monthly, and may 
not be at the same level as what would be found in rations in the feed bunk. Overall, it 
seems as though reducing the dietary VA in feedlot cattle to 25% of NRC (1996) 
recommendations would not negatively affect immune responsiveness, however larger 
scale feedlot studies should be conducted to ensure this is true at a commercial level. 
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6. DISCUSSION
Three main conclusions can be drawn from the two experiments of this study: there was a 
lack of support for a previously discovered ADH1C x VA MAM strategy; findings were 
in agreement with prior knowledge on the effects of hormone implants; and there were no 
significant results suggesting that limiting VA to as low as 25% of NRC (1996) 
recommendations would harm immune function in beef cattle.  
In the trial analyzing markers of immune function, there was no significant effect 
of VA on any of the parameters measured. Significant pen effects were not clinically 
abnormal, and therefore were no cause for concern. The ADH1C genotype effect on IL-4 
expression, where CC animals had significantly lower expression, was interesting, 
however did not point to CC animals being at risk of lessened immune function. 
Although transcription does not always correlate to protein production, prior studies on 
VA limitation (Gorocica-Buenfil et al., 2008; Jee et al., 2013) did not identify significant 
differences in immune function between low and high fed levels of VA either, and 
suggested a severe limitation would be required to lead to these observable changes. Our 
research supports this, in that limiting dietary VA to as low as 25% of NRC 
recommendations did not display any negative effects on measured indicators of immune 
function. 
These results should be taken with some caution however, for a few reasons. The 
sample size was small, although this is common for these types of PBMC studies. The 
animals studied were housed in a smaller feedlot, not a large-scale commercial operation, 
and therefore may have faced less stressors and disease challenge. Lastly, monthly oral 
boluses were used to dose the animals with their respective levels of VA, where a feedlot 
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would typically provide it in the ration. Given these limitations of the immunology 
portion of this study, the proportion of sick/treated/railed/condemned carcass/prematurely 
dead animals per pen in the commercial feedlot study was also considered. No significant 
differences between VA treatments that were included in the feed were observed. This 
suggests that a VA limitation of 50% of NRC recommendations would be safe, however 
more research at a commercial feedlot level would be valuable. 
The commercial feedlot carcass trial resulted in only one interaction effect of 
ADH1C x IMS on ADG and main effects of IMS on DMI, TOTDOF, VGUSYLD, 
VGMARB, REA, and FAT. There were no other significant interaction or main effects. 
The lack of a significant VA x ADH1C effect was unexpected as Ward et al. (2012) and 
Krone et al. (2016) had both shown this interaction effect on fat traits in their smaller 
feedlot studies. There are a number of differences between the Ward et al. (2012) and 
Krone et al. (2016) trials and this one, which may be why we did not observe the 
anticipated interaction effect. 
The sample size of this study was much smaller as pen was the unit. There were 
only 5 pens per treatment, but 36-50 steers per pen from which pen averages were 
calculated. The prior Ward et al. (2012) and Krone et al. (2016) VA x ADH1C studies 
used 130 and 117 steers respectively and each animal was the unit of measure. Although 
not statistically appropriate due to VA being applied to the bunk of the pen instead of on 
an animal-by-animal basis, analysis at the individual (as the unit) level still did not show 
the expected interaction effect (N = 1952). It was also important for the pen to be the unit 
in this study because profiting from grid marketing schemes requires consistently well-
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marbled cattle, and therefore consistency at a pen level would be important for this MAM 
strategy.  
This study attempted to be as commercially applicable as possible; therefore VA 
was fed directly, mixed in with the daily feed ration as opposed to a monthly oral bolus. 
Because of this, we are unsure exactly how much VA each animal consumed and how 
much the timing of the dose had an effect. The fact that pen was the unit of measurement 
should account for variations in the amount of VA consumed by each animal. With 
monthly oral boluses, animals have no supplemental VA all month until the one complete 
dose. This dosage is different from feeding VA daily in the feed, and may have resulted 
in lower fed VA levels in Ward et al. (2012) and Krone et al. (2016) than anticipated as a 
large dose all at once may have meant it was not all absorbed. 
A study by Kruk et al. (2008) cited epigenetic effects as a potential reason for the 
drop in plasma retinol they observed in their animals shortly before slaughter. They stated 
that the stress from shipping 1000 km away from the feedlot to an abattoir, where they 
were processed might have reduced the VA stores of the cattle. In the Ward et al. (2012) 
and Krone et al. (2016) studies, the animals travelled for approximately 10 hours (over 
750 km) in the middle of the summer months from the feedlot to the processing facility. 
Due to the feedlot and packing plant being in close proximity, the steers in this study only 
travelled 130 km before processing. This may account for some of the differences in 
results between the earlier studies and the current one. The animals in the Ward et al. 
(2012) and Krone et al. (2016) studies may have had a drop in VA stores within the last 
several days of life, and this may not have occurred in the steers of the current study. The 
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drop in VA may have allowed for slightly more IMF to accumulate in the cattle in earlier 
studies than the current one.  
The CT and CC animals at the ADH1C SNP were analyzed separately in Ward et 
al. (2012) and Krone et al. (2016), while some CT pens in this study needed to be 
supplemented with CC animals because there were not enough CT animals to fill all pens. 
Previous studies (Ward et al., 2012; Krone et al., 2016) showed CT and CC animals to 
not be significantly different when it came to fat traits, and removing the CC animals for 
the pen averages also did not change significance in this study. 
The steers used in Ward et al. (2012) and Krone et al. (2016) were all black in 
colour and because cattle with at least one ED allele at MC1R (which makes them black) 
have significantly higher fat measurements than red animals (or ee at MC1R; McLean and 
Schmutz, 2009), they may have been more predisposed to have better IMF deposition. 
Again, to make this study as commercially relevant as possible, steers of all colours were 
used, however this may be why we did not see the same significant ADH1C X VA 
results. Non-implanted animals were therefore tested for the MC1R SNP, and results were 
analyzed in only the black animals (however this is not statistically appropriate with 
animal as the unit) and also by analyzing each pen as two groups per pen (by splitting the 
black from non-black animals).  Analyses including any possible effect of MC1R on our 
results were also not significant. 
Implant status was another possible confound as the Ward et al. (2012) and Krone 
et al. (2016) steers were all non-implanted because hormone implants are associated with 
reductions in IMF in cattle (Ducket et al., 1999). By analyzing the IMP and NI pens 
separately, the ADH1C X VA interaction was still not significant. Given our statistical 
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model, any IMS effects on the ADH1C X VA interaction should have appeared to be 
significant as an IMS X ADH1C X VA interaction, but it was not.  
The effect of limiting VA on fat traits in beef cattle has been shown multiple 
times before (Oka et al., 1998; Kruk et al., 2008; Pickworth et al., 2012a; Pickworth et 
al., 2012b), therefore it is unexpected to not at least have significant VA main effects in 
the current study. Ward et al. (2012) did not supplement any of the steers in their study 
during the backgrounding period and went on to supplement either 0% or 100% NRC 
recommended levels of VA during finishing. This study by Ward et al. (2012) also 
observed the most convincing IMF differences between the groups of low and high 
supplemented animals when compared to the results of the other two phases of this 
project (Krone et al., 2016; and the current study). This would suggest that a more drastic 
VA limitation, and likely for a longer period of time, would be required to observe 
significant differences in fat traits for this MAM strategy. At a commercial feedlot level it 
would likely be difficult to also limit VA in backgrounding due to many feedlots only 
feeding animals during finishing. It would be quite risky to implement such severe 
limitations at a commercial level as well because animals entering the feedlot would have 
varying levels of stored VA, and those on the lower end of the spectrum would be 
susceptible to deficiency. From a practical standpoint, it would be very difficult to more 
drastically limit dietary VA as silage would likely have to not be used at all, or would 
have to be completely deficient of VA, which is unlikely. The lowest possible level of 
VA for the current trial was 50% of NRC due to the amount of VA in the silage. For TT 
animals at the ADH1C SNP, limiting VA more severely and for a longer period of time 
may lead to improved fat traits, however this is likely not feasible at a commercial level. 
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No ADH1C main effects were observed in this study. This is not surprising as 
Ward et al. (2012) and Krone et al. (2016) also did not observe the genotype effects 
unless VA was limiting. Mizoguchi et al. (2014) however, stated that the 
CCAAT/enhancer binding protein α binding site is not detectable in bovine intramuscular 
preadipocyte cell lines. This binding site was critical in the theory by Ward et al. (2012) 
that the presence of the C allele would remove the binding site and cause ADH1C 
expression to be reduced in CC compared to TT animals. Ward et al. (2012) and Krone et 
al. (2016) showed that there was both increased expression of the ADH1C gene and 
increased concentrations of the ADH1C protein respectively in liver of TT when 
compared to CC animals. This would suggest that the theory by Ward et al. (2012) was 
correct, unless there is another transcription factor binding site at the same location that is 
altered in a similar way to CCAAT/enhancer binding protein α by the ADH1C SNP. 
The observed ADH1C X IMS interaction effect on ADG is likely just a main 
effect of IMS as ADG does not differ by genotype in the NI pens, and the difference 
between genotypes in the IMP pens is very small. It is possible that CT animals may have 
increased ADG, as this interaction suggests, as they were the more lean animals of the 
group and may gain muscle mass ahead of fat as in the TT animals. This only occurred in 
the IMP pens however, which at this point is unexplainable. The significant effects of 
IMS on ADG (although in combination with genotype), DMI, TOTDOF, VGUSYLD, 
VGMARB, REA, and FAT are not surprising, and have been observed in prior studies 
(Foutz et al., 1997; Platter et al., 2003; Wileman et al., 2009). These significant findings 
support the overall intended effects of hormone implants – to improve production traits 
and yield. Their downside however is the negative effect they have on marbling and fat 
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traits. Depending on which marketing system a producer intends to target, these benefits 
and consequences of growth promotants are important to keep in mind.  
Although the results of the commercial feedlot trial were both unexpected and 
disappointing, the lack of significant results in the immunology population is 
encouraging. While the ADH1C x VA MAM strategy may not be effective at a feedlot 
level, it is likely that the NRC recommendation of 2200 IU/kg DMI is much more than is 
required. Limiting dietary VA may still be a useful feedlot strategy, and SNPs in other 
genes may influence the VA-adipogenesis pathway in a manner that could support their 
use in MAM. 
69 
7. REFERENCES
Adachi, K., Kawano, H., Tsuno, K., Nomura, Y., Yamamoto, N., Arikawa, A., Tsuji, 
A., Adachi, M., Onimaru, T., and Ohwada, K. 1999. Relationship between serum 
biochemical values and marbling scores in Japanese black steers. Journal of Veterinary 
Medical Science 61: 961-964. 
Anderson, J. and Young, L. 2008. Fat-Soluble Vitamins. Food and Nutrition series, 
Colorado State University 9: 315. 
Bardot, O., Aldridge, T.C., Latruffe, N., and Green, S. 1993. PPAR-RXR heterodimer 
activates a peroxisome proliferators response element upstream of the bifunctional 
enzyme gene. Biochemical and Biophysical Research Communications 192: 37-45. 
Blomhoff, R., Green, M.H., Berg, R., and Norum, K.R. 1990. Transport and storage of 
vitamin A. Science 250: 399-404. 
Boleda, M.D., Saubi, N., Farrés, J., and Parés, X. 1993. Physiological substrates for rat 
alcohol dehydrogenase classes: aldehydes of lipid peroxidation, ω-hydroxyfatty acids, 
and retinoids. Archices of Biochemistry and Biophysics 307: 85-90. 
Boleman, S.J., Boleman, S.L., Miller, R.K., Taylor, J.F., Cross, H.R., Wheeler, T.L., 
Koohmaraie, M., Shackelford, S.D., Miller, M.F., West, R.L., Johnson, D.D., and 
Savell, J.W. 1997. Consumer evaluation of beef of known categories of tenderness. 
Journal of Animal Science 75(6): 1521-1524. 
Bricarello, P.A., Zaros, L.G., Coutinho, L.L., Rocha, R.A., Silva, M.B., Kooyman, 
F.N.J., De Vries, E., Yatsuda, A.P., and Amarante, A.F.T. 2008. Immunological 
responses and cytokine gene expression analysis to Cooperia punctate infections in 
resistant and susceptible Nelore cattle. Veterinary Parasitology 155: 95-103. 
Bruns, K. W., R. H. Pritchard, and Boggs, D. L. 2005. The effect of stage of growth 
and implant exposure on performance and carcass composition in steers. Journal of 
Animal Science 83: 108-116. 
Bryant, T.C., Wagner, J.J., Tatum, J.D., Galyean, M.L., Anthony, R.V., and Engle, 
T.E. 2010. Effect of dietary supplemental vitamin A concentration on performance, 
carcass merit, serum metabolites, and lipogenic enzyme activity in yearling beef steers. 
Journal of Animal Science 88: 1463-1478. 
Buchanan, F.C., Fitzsimmons, C.J., Van Kessel, A.G., Thue, T.D., Winkelman-Sim, 
D.C., and Schmutz, S.M. 2002. Association of a missense mutation in the bovine leptin
gene with carcass fat content and leptin mRNA levels. Genetics Selection Evolution 34:
105-116.
70 
Buchanan, F.C., Van Kessel, A.G., Boisclair, Y.R., Block, H.C., and McKinnon, J.J. 
2007. The leptin arg25cys affects performance, carcass traits and serum leptin 
concentrations in beef cattle. Canadian Journal of Animal Science 87(2): 153-156. 
Bugge, T.H., Pohl, J., Lonnoy, O., and Stunnenberg, H.G. 1992. RXR alpha, a 
promiscuous partner of retinoic acid and thyroid hormone receptors. The EMBO Journal 
11: 1409-1418. 
Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., 
Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L, Vandesompele, J., and Wittwer, 
C.T. 2009. The MIQE Guidelines: Minimum Information for Publication of Quantitative
Real-Time PCR Experiments. Clinical Chemistry 55(4): 611-622.
Canadian Council on Animal Care. 1993. Guide to the care and use of experimental 
animals. Vol. 1. Canadian Council Animal Care, Ottawa, ON.  
CFIA. 2014. Chemical Residues. In Meat Hygiene Manual of Procedures. Retrieved 
from http://www.inspection.gc.ca/food/meat-and-poultry-products/manual-of-
procedures/chapter-5/eng/1395150894222/1395150895519?chap=2#s13c2 on October 
15th, 2015.  
Coussens, P.M., Verman, N., Coussens, M.A., Elftman, M.D., and McNulty, A.M. 
2004. Cytokine gene expression in peripheral blood mononuclear cells and tissues of 
cattle infected with Mycobacterium avium subsp. Paratuberculosis: Evidence for and 
inherent proinflammatory gene expression pattern. Infection and immunity 72(3): 1409-
1422. 
Curley Jr., K.O. 2004. Influence of temperament on bovine hypothalamic-pituitary-
adrenal function. M.S. thesis, Texas A&M University, College Station. 
Dawson, M.I. 2000. The importance of vitamin A in nutrition. Current Pharmaceutical 
Design 6(3): 311-325. 
Deming, D. M. and Erdman, J. W. Jr. 1999. Mammalian carotenoid absorption and 
metabolism. Pure and Applied Chemistry 71: 2213-2223. 
Desvergne, B. 2007. RXR: from partnership to leadership in metabolic regulations. 
Vitamins & Hormones. 75: 1-35. 
DiCostanzo, A. and Dahlen, C.R. 2000. Grid pricing as a fed cattle marketing strategy. 
Minnesota Cattle Feeder Report B-470. University of Minnesota, St. Paul, MN, USA. 
DiRenzo, J., Söderström, M., Kurokawa, R., Ogliastro, M. H., Ricote, M., Ingrey, S., 
Hörlein, A., Rosenfeld, M.G., and Glass, C.K. 1997. Peroxisome proliferators- 
activated receptors and retinoic acid receptors differentially control the interactions of 
71 
retinoid X receptor heterodimers with ligands, coactivatrors, and corepressors. Molecular 
and Cellular Biololgy 17: 2166-2176. 
DSM Nutritional Products Green Book. 2004. Determination of beta-carotene and 
lycopene. DSM Nutritional Products, Basel, Switzerland. 
Duckett, S.K., Wagner, D.G., Owens, F.N., Dolezal, H.G., and Gill, D.R. 1999. Effect 
of anabolic implants on beef intramuscular lipid content. Journal of Animal Science 77: 
1100-1104. 
Duester, G. 2000. Families of retinoid dehydrogenases regulating vitamin A function: 
production of visual pigment and retinoic acid. European Journal of Biochemistry 267: 
4315-4324. 
Eroglu, A., D. P. Hruszkewycz, C. Sena, S. Narayanasamy, K. M. Reidl, R. E. 
Kopec, S. J. Schwartz, R. W. Curley, and Harrison, E. H. 2012. Naturally occurring 
eccentric cleavae products of provitamin A β-carotene function as antagonists of retinoic 
acid receptors. Journal of Biological Chemistry 287: 15886-15895. 
Feuz, D.M. 1999. Market signals in value-based pricing premiums and discounts. Journal 
of Agricultural and Resource Economics 24(2): 327-341. 
Foutz, C.P., Dolezal, H.G., Gardner, T.L., Gill, D.R., Hensley, J.L., and Morgan, 
J.B. 1997. Anabolic implant effects on steer performance, carcass traits, subprimal yields, 
and longissimus muscle properties. Journal of Animal Science 75: 1256-1265. 
Froehlich, E.J., Carlberg, J.G., and Ward, C.E. 2009. Willingness-to-pay for fresh 
brand name beef. Canadian Journal of Agricultural Economics 57: 119-137. 
Gibb, D.J., Van Herk, F.H., Mir, P.S., Loerch, S., and McAllister, T.A. 2011. 
Removal of supplemental vitamin A from barley-based diets improves marbling in 
feedlot heifers. Canadian Journal of Animal Science 91: 1-6. 
Ginzinger, D.G. 2001. Gene quantification using real-time quantitative PCR: An 
emerging technology hits the mainstream. Experimental Hematology 30: 503-512. 
Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R., and Mathieu, 
C. 2001. An overview of real-time quantitative PCR: Applications to quantify cytokine
gene expression. Methods 25: 386-401.
Goodman, D.S. 1984. Plasma retinol-binding protein. Pages 42-88 in Sponr, M.B., 
Roberts, A.B., and Goodman, D.S., eds. The Retinoids. Vol. 2. Academic Press, Orlando, 
Florida. 
72 
Gorocica-Buenfil, M.A., Fluharty, F.L., and Loerch, S.C. 2008. Effect of vitamin A 
restriction on carcass characteristics and immune status of beef steers. Journal of Animal 
Science 86: 1609-1616. 
Gregoire, F.M., Smas, C.M., and Sul, H.S. 1998. Understanding adipocyte 
differentiation. Physiological Reviews 78(3): 783-809. 
Harper, G.S. and Pethick, D.W. 2004. How might marbling begin? Australian Journal 
of Experimental Agriculture 44: 653-662.  
Harrison, E.H. 2005. Mechanisms of digestion and absorption of dietary vitamin A. 
Annual Review of Nutrition 25: 87-103. 
Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele, G., Evans, R.M., 
and Thaller, C. 1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X 
receptor. Cell 68: 397-406. 
Hidiroglou, M. and Markham, F. 1996. Effect of oral supplements of vitamin A on the 
plasma retinol levels in calves and their immunological unresponsiveness. Reproduction 
Nutrition Development 36: 467-472. 
Hill, B.D., Holroyd, R.G., and Sullivan, M. 2009. Clinical and pathological findings 
associated with congenital hypovitaminosis A in extensively grazed beef cattle. 
Australian Veterinary Journal 87(3): 94-98. 
Jee, J., Hoet, A.E., Azevedo, M.P., Vlasova, A.N., Loerch, S.C., Pickworth, C.L., 
Hanson, J., and Saif, L.J. 2013. Effects of dietary vitamin A content on antibody 
responses of feedlot calves inoculated intramuscularly with an inactivated bovine 
coronavirus vaccine. American Journal of Veterinary Research 74(10): 1353-1362. 
Kauffman, R.G., Van Ess, M.E., Long, R.A., and Schaefer, D.M. 1975. Marbling: Its 
use in predicting beef carcass composition. Journal of Animal Science 40(2): 235-241. 
Kawada, T., Kamei, Y., and Sugimoto, E. 1996. The possibility of active form of 
vitamins A and D as suppressors on adipocyte development via ligand-dependent 
transcriptional regulators. International Journal of Obesity and Related Metabolic 
Disorders 20(Suppl. 3): S52-S57. 
Kawada, T., Kamei, Y., Fujita, A., Hida, Y., Takahashi, N., Sugimoto, E., and 
Fushiki, T. 2000. Carotenoids and retinoids as suppressors on adipocyte differentiation 
via nuclear receptors. Biofactors 13: 103-109. 
Killinger, K.M., Calkins, C.R., Umbergert, W.J., Feuz, D.M., and Eskridge, K.M. 
2004. Consumer sensory acceptance and value for beef steaks of similar tenderness but 
differing marbling level. Journal of Animal Science 82: 3294-3301. 
73 
King, D.A., Schuehle Pfeiffer, C.E., Randel, R.D., Welsh Jr., T.H., Oliphint, R.A., 
Baird, B.E., Curley Jr., K.O., Vann, R.C., Hale, D.S., and Savell, J.W. 2006. 
Influence of animal temperament and stress responsiveness on the carcass quality and 
beef tenderness of feedlot cattle. Meat Science 74: 546-556. 
Klungland, H., Vage, D.I., Gomez-Raya, L., Adalsteinsson, S., and Lien, S. 1995. The 
role of melanocyte-stimulating hormone (MSH) receptor in bovine coat color 
determination. Mammalian Genome 6: 636-639. 
Kononoff, P.J., Defoor, P.J., Engler, M.J., Swingle, R.S., James, S.T., Deobald, 
H.M., Deobald, J.L., and Marquess, F.L. 2013. Impact of a leptin single nucleotide
polymorphism and zilpaterol hydrochloride on growth and carcass characteristics in
finishing steers. Journal of Animal Science 91(10): 5011-5017.
Krone, K.G., Ward, A.K., Madder, K.M., Hendrick, S., McKinnon, J.J., and 
Buchanan, F.C. 2016. Interaction of vitamin A supplementation level with ADH1C 
genotype on intramuscular fat in beef steers. Animal 10(3): 403-409. 
Kruk, Z.A., Bottema, C.D.K., Davis, J.J., Sievert, B.D., Harper, G.S., Di, J., and 
Pitchford, W.S. 2008. Effects of vitamin A on growth performance and carcass quality 
in steers. Livestock Science 119: 12-21.  
Li-Weber, M., Giaisi, M., Treiber, M.K., and Krammer, P.H. 2002. Vitamin E 
inhibits IL-4 gene expression in peripheral blood T cells. European Journal of 
Immunology 32: 2401-2408. 
Livak, K.J. and Schmittgen, T.D. 2001. Analysis of relative gene expression data using 
real-time quantitative PCR and the 2(-Delta Delta C(t)) method. Methods 4: 402-408. 
Luby, C. 2010. Bovine mammary cellular immune responses to Stapholococcus aureus 
(Unpublished doctoral thesis). University of Saskatchewan, Saskatoon, Canada. 
Malek, T.R., Yu, A., Vincek, V., Scibelli, P., and Kong, L. 2002. CD4 regulatory T 
cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: Implications for the 
nonredundant function of IL-2. Immunity 17: 167-178. 
McDowell, L. R. 1989. Vitamins in Animal Nutrition. Academic Press Inc. Harcourt 
Brace Jovanovich Publishers, San Diego, CA. 
McLean, K.L. and Schmutz, S.M. 2009. Associations of melanocortin 1 receptor 
genotype with growth and carcass traits in beef cattle. Canadian Journal of Animal 
Science 89: 295-300. 
Medzhitov, R. and Janeway Jr., C.A. 1997. Innate Immunity: The Virtues of a 
Nonclonal System of Recognition. Cell 91: 295-298. 
74 
Mizoguchi, Y., Moriya, M., Taniguchi, D., and Hasegawa, A. 2014. Effect of retinoic 
acid on gene expression profiles of bovine intramuscular preadipocytes during 
adipogenesis. Animal Science Journal 85: 101-111. 
Mosmann, T.R. and Coffman, R.L. 1989. Th1 and Th2 Cells: Different Patterns of 
Lymphokine Secretion Lead to Different Functional Properties. Annual Review of 
Immunology 7: 145-173. 
Napoli, J.L. 1996. Retinoic acid biosynthesis and metabolism. FASEB Journal 10: 993-
1001. 
NRC. 1970. Nutrient requirements of beef cattle. 4th rev. ed. Natl. Acad. Pres., 
Washington, DC. 
NRC. 1996. Nutrient requirements of beef cattle. 7th rev. ed. Natl. Acad. Press., 
Washington, DC.  
Neely, T.R., Lorenzen, C.L., Miller, R.K., Tatum, J.D., Wise, J.W., Taylor, J.F., 
Buyck, M.J., Reagan, J.O., and Savell, J.W. 1998. Beef customer satisfaction: Role of 
cut, USDA quality grade, and city on in-home consumer ratings. Journal of Animal 
Science 76: 1027-1032. 
Ohyama, M., Matsuda, K., Torii, S., Matsui, T., Yano, H., Kawada, T., and 
Ishihara, T. 1998. The interaction between vitamin A and thiazolidinedione on bovine 
adipocyte differentiation in primary culture. Journal of Animal Science 76: 61-65. 
Oka, A., Maruo, Y., Miki, T., Yamasaki, T., and Saito, T. 1998. Influence of vitamin 
A on the quality of beef from the Tajima strain of Japanese Black cattle. Meat Science 
48: 159-167. 
Peterhans, E., Jungi, T.W., and Schweizer, M. 2003. BVDV and innate immunity. 
Biologicals 31: 107-111.  
Petkovich, P.M. 2001. Retinoic acid metabolism. Journal of the American Acadademy 
of Dermatology 45: S136-142. 
Pickworth, C.L., Loerch, S.C., and Fluharty, F.L. 2012. Restriction of vitamin A and 
D in beef cattle finishing diets on feedlot performance and adipose accretion. Journal of 
Animal Science 90: 1866-1878. 
Pickworth, C.L., Loerch, S.C., and Fluharty, F.L. 2012. Effects of timing and duration 
of dietary vitamin A reduction on carcass quality of finishing beef cattle. Journal of 
Animal Science 90: 2677-2691. 
75 
Platter, W.J., Tatum, J.D., Belk, K.E., Scanga, J.A., and Smith, G.C. 2003. Effects of 
repetitive use of hormonal implants on beef carcass quality, tenderness, and consumer 
ratings of beef palatability. Journal of Animal Science 81: 984-996. 
Platter, W.J., Tatum, J.D., Belk, K.E., Koontz, S.R., Chapman, P.L., and Smith, 
G.C. 2005. Effects of marbling and shear force on consumers’ willingness to pay for beef
strip loin steaks. Journal of Animal Science 83: 890-899.
Quadro, L., Hamberger, L., Colantuoni, V., Gottesman, M.E., and Blaner, W.S. 
2003. Understanding the physiological role of retinol-binding protein in vitamin A 
metabolism using transgenic and knockout mouse models. Molecular Aspects of 
Medicine 24: 421-430. 
Quadro, L., Blaner, W. S., Hamberger, L., Novikoff, P. M., Vogel, S., Piantedosi, R., 
Gottesman, M. E., and Colantuoni, V. 2004. The role of extrahepatic retinol binding 
protein in the mobilization of retinoid stores. Journal of Lipid Research 45: 1975-1982. 
Radostitis, O.M., Gay, C.C., and Blood, D.C. 2000. Diseases caused by deficiencies of 
fat-soluble vitamins. In: Veterinary medicine: a textbook of the diseases of cattle, sheep, 
pigs, goats and horses. 9th Edition. WB Saunders, London, 1550-1552. 
Repa, J.J., Hanson, K.K., and Clagett-Dame, M. 1993. All-trans-retinol is a ligand for 
the retinoic acid receptors. PNAS 90: 7293-7297. 
Savell, J.W., Branson, R.E., Cross, H.R., Stiffler, D.M., Wise, J.W., Griffin, D.B., 
and Smith, G.C. 1987. National Consumer Retail Beef Study: Palatability evaluations of 
beef loin steaks that differed in marbling. Journal of Food Science 52: 517-519, 532. 
Semba, R.D. 1998. The Role of Vitamin A and Related Retinoids in Immune Function. 
Nutrition Reviews 56(1): S38-S48.  
Shackleford, S.D., Wheeler, T.L., Meade, M.K., Reagan, J.O., Byrnes, B.L., and 
Koohmaraie, M. 2001. Consumer impressions of Tender Select beef. Journal of Animal 
Science 79: 2605-2614. 
Siebert, B.D., Pitchford, W.S., Kuchel, H., Kruk, Z.A., and Bottema, C.D.K. 2000. 
The effect of b-carotene on desaturation of ruminant fat. Asian-Australian Journal of 
Animal Science 13: 185-188 (Suppl.). 
Simms, D., Cizdziel, P.E., and Chomczynski, P. 1993. TRIzol: A new reagent for 
optimal single-step isolation of RNA. Focus 15(4): 99-102. 
Spears, J. W. 2000. Micronutrients and immune function in cattle. Proceedings of the 
Nutrition Society 59: 1-8. 
76 
Stephensen, C.B. 2001. Vitamin A, Infection, and Immune Function. Annual Review of 
Nutrition 21: 167-192.  
Thacker, T.C., Palmer, M.V., and Waters, W.R. 2007. Associations between cytokine 
gene expression and pathology in Mycobacterium bovis infected cattle. Veterinary 
Immunology and Immunopathology 119: 204-213. 
Thompson, N.M., DeVuyst, E.A., Brorsen, B.W., and Lusk, J.L. 2014. Value of 
genetic information for beef cattle at the feedlot stage. Southern Agricultural Economics 
Association Annual Meeting, Dallas, TX. February 1-4, 2014. 
Tizard, I.R. 2000. Regulation of the acquired immune response. In: Veterinary 
immunology: an introduction. 6th Edition. WB Saunders, Philadelphia, 180-190. 
Van Eenennaam, A.L., Li, J., Thallman, R.M., Quaas, R.L., Dikeman, M.E., Gill, 
C.A., Franke, D.E., and Thomas, M.G. 2007. Validation of commercial DNA tests for
quantitative beef quality traits. Journal of Animal Science 85: 891-900.
Van Eenennaam, A.L. and Drake, D.J. 2012. Where in the beef-cattle supply chain 
might DNA tests generate value? Animal Production Science 52: 185-196. 
VanGuilder, H.D., Vrana, K.E., and Freeman, W.M. 2008. Twenty-five years of 
quantitative PCR for gene expression analysis. BioTechniques 44: 619-626. 
Wang, W.J., Wang, S.P., Gong, Y.S., Wang, J.Q., and Tan, Z.L. 2007. Effects of 
vitamin A supplementation on growth performance, carcass characteristics and meat 
quality in Limosin x Luxi crossbred steers fed a wheat straw-based diet. Meat Science 77: 
450-458.
Ward, A.K., McKinnon, J.J., Hendrick, S., and Buchanan, F.C. 2012. The impact of 
vitamin A restriction and ADH1C genotype on marbling in feedlot steers. Journal of 
Animal Science 90: 1-8.  
Whale, T.A., Wilson, H.L., Tikoo, S.K., Babiuk, L.A., and Griebel, P.J. 2006. Pivotal 
advance: Passively acquired membrane proteins alter the functional capacity of bovine 
polymorphonuclear cells. Journal of Leukocyte Biology 80: 481-491. 
Wileman, B.W., Thomson, D.U., Reinhardt, C.D., and Renter, D.G. 2009. Analysis of 
modern technologies commonly used in beef cattle production: Conventional beef 
production versus nonconventional production using meta-analysis. Journal of Animal 
Science 87: 3418-3426. 
Zhang, X.K., Lehmann, J., Hoffman, B., Dawson, M.I., Cameron, J., Graupner, G., 
Herman, T., Tran, P., and Pfahl, M. 1992. Homodimer formation of retinoid X 
receptor induced by 9-cis retinoic acid. Nature 358: 587-591. 
77 
Zheng, S.G., Wang, J.H., Gray, J.D., Soucier, H., and Horwitz, D.A. 2004. Natural 
and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: 
The tole of IL-2, TGF-β, and IL-10. The Journal of Immunology 172: 5213-5221. 
Ziouzenkova, O., Orasanu, G., Sharlach, M., Akiyama, T.E., Berger, J.P., Viereck, 
J., Hamilton, J.A., Tang, G., Dolnikowski, G.G., Vogel, S., Duester, G., and Plutzky, 
J. 2007. Retinaldehyde represses adipogenesis and diet-induced obesity. Nature Medicine
13: 695-702.
A
P
P
E
N
D
IC
E
S
 
A
P
P
E
N
D
IX
 A
 
Im
m
u
n
e 
fu
n
ct
io
n
 i
n
d
ic
a
to
r 
m
ea
su
re
m
en
ts
 b
y 
a
n
im
a
l 
fo
r 
a
) 
w
h
o
le
 b
lo
o
d
 c
el
l 
co
u
n
ts
, 
a
n
d
 b
) 
P
B
M
C
 s
ti
m
u
la
ti
o
n
 a
n
d
 g
en
e 
ex
p
re
ss
io
n
 d
a
ta
 
a
) A
n
im
a
l 
A
D
H
1
C
 
P
en
 
V
A
 (
%
) 
W
B
C
 
S
E
G
S
 
B
A
N
D
S
 
R
B
C
 
T
O
T
-
P
R
O
T
 
F
IB
 
1
2
-0
2
5
 
C
C
 
9
 
2
5
 
9
.6
 
2
.1
1
2
 
0
.0
0
0
 
9
.9
2
 
7
6
 
2
 
1
2
-0
4
3
 
C
T
 
9
 
2
5
 
5
.5
 
0
.6
0
5
 
0
.0
0
0
 
8
.5
8
 
8
1
 
1
 
1
2
-0
5
2
 
T
T
 
1
0
 
7
5
 
7
.7
 
2
.3
1
0
 
0
.0
0
0
 
7
.2
3
 
8
5
 
4
 
1
2
-0
6
5
 
T
T
 
9
 
2
5
 
7
.2
 
1
.8
7
2
 
0
.0
0
0
 
1
0
.3
0
 
7
6
 
2
 
1
2
-0
6
6
 
C
C
 
1
0
 
2
5
 
1
1
.8
 
4
.9
5
6
 
0
.1
1
8
 
8
.1
5
 
7
9
 
4
 
1
2
-0
7
5
 
T
T
 
1
0
 
2
5
 
1
3
.4
 
2
.0
1
0
 
0
.0
0
0
 
8
.1
2
 
8
3
 
3
 
1
2
-0
7
7
 
T
T
 
9
 
7
5
 
6
.6
 
1
.5
1
8
 
0
.0
0
0
 
6
.9
2
 
8
0
 
3
 
1
2
-1
0
4
 
T
T
 
1
0
 
2
5
 
1
1
.3
 
2
.0
3
4
 
0
.1
1
3
 
8
.8
0
 
7
9
 
4
 
1
2
-1
7
2
 
C
T
 
9
 
7
5
 
8
.7
 
1
.6
5
3
 
0
.0
0
0
 
8
.1
8
 
7
5
 
2
 
1
2
-1
8
6
 
C
C
 
1
0
 
7
5
 
7
.9
 
1
.8
9
6
 
0
.0
0
0
 
8
.4
0
 
7
8
 
3
 
1
2
-1
9
9
 
C
T
 
1
0
 
2
5
 
7
.1
 
1
.0
6
5
 
0
.0
0
0
 
8
.4
4
 
7
8
 
3
 
1
2
-2
0
6
 
T
T
 
1
0
 
7
5
 
8
.8
 
1
.5
8
4
 
0
.0
0
0
 
9
.1
5
 
8
0
 
5
 
1
2
-2
1
0
 
C
T
 
1
0
 
7
5
 
1
1
.9
 
4
.9
9
8
 
0
.0
0
0
 
9
.0
7
 
8
0
 
4
 
1
2
-2
4
9
 
C
C
 
9
 
2
5
 
1
1
.0
 
2
.9
7
0
 
0
.0
0
0
 
7
.6
1
 
7
8
 
2
 
1
2
-2
9
7
 
C
T
 
9
 
7
5
 
8
.1
 
1
.9
4
4
 
0
.0
0
0
 
8
.6
4
 
7
1
 
3
 
1
2
-3
5
8
 
C
C
 
9
 
7
5
 
6
.4
 
1
.2
8
0
 
0
.0
0
0
 
1
1
.1
 
8
0
 
2
 
1
2
-4
2
8
 
C
C
 
1
0
 
7
5
 
1
0
.1
 
2
.8
2
8
 
0
.0
0
0
 
8
.4
3
 
8
0
 
4
 
1
2
-4
4
6
 
C
T
 
1
0
 
2
5
 
7
.6
 
2
.9
6
4
 
0
.0
0
0
 
8
.5
1
 
7
3
 
3
 
78
b
) A
n
im
a
l 
A
D
H
1
C
 
P
en
 
V
A
 (
%
) 
S
T
IM
 
IL
-2
 
IL
-4
 
IL
-5
 
IL
-1
0
 
IF
N
-γ
 
1
2
-0
2
5
 
C
C
 
9
 
2
5
 
1
2
.0
9
 
0
.6
1
1
3
 
. 
7
.2
1
0
0
 
0
.1
5
5
0
 
0
.8
7
0
6
 
1
2
-0
4
3
 
C
T
 
9
 
2
5
 
2
0
.3
3
 
0
.0
0
0
2
 
. 
0
.0
0
0
1
 
. 
. 
1
2
-0
5
2
 
T
T
 
1
0
 
7
5
 
2
5
.8
7
 
0
.4
0
9
0
 
3
4
1
.3
2
4
5
 
9
.2
5
3
5
 
0
.2
0
0
3
 
0
.0
5
5
6
7
 
1
2
-0
6
5
 
T
T
 
9
 
2
5
 
8
.5
5
 
5
.2
5
9
8
 
5
.3
5
1
7
 
8
6
2
9
.1
3
3
6
 
1
.9
6
5
6
 
2
.6
1
1
7
 
1
2
-0
6
6
 
C
C
 
1
0
 
2
5
 
2
.7
5
 
0
.6
6
2
0
 
2
.5
8
4
7
 
5
5
2
.5
6
4
9
 
4
.5
6
3
1
 
0
.3
4
1
5
 
1
2
-0
7
5
 
T
T
 
1
0
 
2
5
 
2
4
.0
2
 
1
.2
0
5
8
 
2
5
.2
8
1
3
 
1
3
.0
4
1
2
 
2
.2
1
9
1
 
1
0
.1
2
6
1
 
1
2
-0
7
7
 
T
T
 
9
 
7
5
 
7
.6
8
 
. 
0
.1
0
9
6
 
0
.5
9
4
6
 
. 
0
.2
7
0
7
 
1
2
-1
0
4
 
T
T
 
1
0
 
2
5
 
6
.1
0
 
1
.4
2
4
1
 
2
1
.1
1
2
1
 
1
1
7
0
6
.3
2
0
0
 
1
.7
5
9
3
 
4
.7
0
7
6
 
1
2
-1
7
2
 
C
T
 
9
 
7
5
 
8
1
.9
5
 
1
.6
7
6
0
 
1
8
.6
3
5
7
 
1
9
3
0
.8
2
2
7
 
0
.6
6
6
6
 
2
.1
8
1
0
 
1
2
-1
8
6
 
C
C
 
1
0
 
7
5
 
2
3
.5
4
 
0
.3
5
7
2
 
3
.9
5
8
6
 
6
0
8
0
.6
0
8
5
 
0
.8
0
3
9
 
1
.5
6
3
7
 
1
2
-1
9
9
 
C
T
 
1
0
 
2
5
 
9
.8
5
 
0
.3
8
0
2
 
6
.4
3
0
8
 
1
9
2
4
.1
4
2
6
 
0
.8
1
5
1
 
0
.6
7
1
3
 
1
2
-2
0
6
 
T
T
 
1
0
 
7
5
 
4
.9
2
 
1
.9
1
8
5
 
2
8
.2
4
6
5
 
1
3
7
7
7
.2
4
6
9
 
1
.7
4
7
1
 
0
.3
7
1
1
 
1
2
-2
1
0
 
C
T
 
1
0
 
7
5
 
4
9
.4
6
 
1
.4
7
9
4
 
3
6
.3
7
8
1
 
9
3
9
.0
1
2
1
 
2
.1
8
8
6
 
1
8
2
.9
1
1
2
 
1
2
-2
4
9
 
C
C
 
9
 
2
5
 
2
.1
2
 
1
.0
8
3
0
 
3
.0
0
0
1
 
2
5
.3
6
9
1
 
1
.7
9
6
3
 
0
.7
6
0
5
 
1
2
-2
9
7
 
C
T
 
9
 
7
5
 
7
.9
8
 
0
.0
0
0
5
 
. 
0
.0
4
8
2
 
0
.0
1
4
8
 
. 
1
2
-3
5
8
 
C
C
 
9
 
7
5
 
5
.5
1
 
2
.8
9
7
9
 
3
.5
0
6
4
 
2
2
1
0
.2
5
9
4
 
1
.7
7
7
7
 
7
.6
4
7
6
 
1
2
-4
2
8
 
C
C
 
1
0
 
7
5
 
6
.2
7
 
0
.1
4
0
6
 
1
.6
2
4
5
 
1
7
6
4
.4
4
6
5
 
2
.1
8
8
6
 
0
.4
5
0
6
 
1
2
-4
4
6
 
C
T
 
1
0
 
2
5
 
1
1
.2
0
 
0
.4
4
1
4
 
5
.0
1
0
7
 
6
5
.7
9
9
3
 
0
.7
3
7
1
 
0
.9
8
2
8
 
A
D
H
1
C
 =
 A
D
H
1
C
c.
-6
4
T
>
C
 g
en
o
ty
p
e;
 P
E
N
 =
 P
en
 a
ll
o
ca
ti
o
n
; 
V
A
 =
 V
it
am
in
 A
 l
ev
el
 a
s 
a 
p
er
ce
n
ta
g
e 
o
f 
th
e 
N
R
C
 (
1
9
9
6
) 
re
q
u
ir
em
en
t;
 W
B
C
 =
 
W
h
it
e 
b
lo
o
d
 c
el
l 
co
u
n
t;
 S
E
G
S
 =
 S
eg
m
en
te
d
 c
el
l 
co
u
n
t;
 B
A
N
D
S
 =
 B
an
d
 n
eu
tr
o
p
h
il
 c
o
u
n
t;
 R
B
C
 =
 R
ed
 b
lo
o
d
 c
el
l 
co
u
n
t;
 T
O
T
P
R
O
T
 =
 T
o
ta
l 
p
ro
te
in
 
co
u
n
t;
 F
IB
 =
 F
ib
ri
n
o
g
en
 c
o
u
n
t;
 S
T
IM
 =
 S
ti
m
u
la
ti
o
n
 i
n
d
ex
 v
al
u
e;
 I
L
-2
 =
 I
n
te
rl
eu
k
in
 2
 g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e;
 I
L
-4
 =
 I
n
te
rl
eu
k
in
 4
 g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e;
 I
L
-5
 =
 I
n
te
rl
eu
k
in
 5
 g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e;
 I
L
-1
0
 =
 I
n
te
rl
eu
k
in
 1
0
 g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e;
 I
F
N
-γ
 =
 I
n
te
rf
er
o
n
 
g
a
m
m
a 
g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e 
79
A
P
P
E
N
D
IX
 B
 
Im
m
u
n
e 
fu
n
ct
io
n
 i
n
d
ic
a
to
r 
m
ea
su
re
m
en
ts
 b
y 
in
d
ep
en
d
en
t 
va
ri
a
b
le
s 
A
D
H
1
C
 g
en
o
ty
p
e 
(a
-b
),
 p
en
 a
ll
o
ca
ti
o
n
 (
c-
d
),
 a
n
d
 v
it
a
m
in
 A
 l
ev
el
 (
e-
f)
 f
o
r 
w
h
o
le
 b
lo
o
d
 c
el
l 
co
u
n
ts
 (
a
, 
c,
 e
) 
a
n
d
 P
B
M
C
 s
ti
m
u
la
ti
o
n
 a
n
d
 g
en
e 
ex
p
re
ss
io
n
 d
a
ta
 (
b
, 
d
, 
f)
 
a
) A
D
H
1
C
 
W
B
C
 
S
E
M
 
S
E
G
S
 
S
E
M
 
B
A
N
D
S
 
S
E
M
 
R
B
C
 
S
E
M
 
T
O
T
-
P
R
O
T
 
S
E
M
 
F
IB
 
S
E
M
 
T
T
 
9
.6
8
 
1
.1
7
 
1
.9
6
 
0
.1
2
 
0
.0
2
3
 
0
.0
2
3
 
8
.7
2
 
0
.5
1
 
8
0
.6
0
 
1
.5
7
 
3
.6
0
 
0
.5
1
 
C
T
 
8
.8
3
 
1
.0
8
 
2
.6
7
 
0
.8
7
 
0
.0
0
0
 
0
.0
0
0
 
8
.5
5
 
0
.1
9
 
7
6
.5
0
 
1
.5
5
 
3
.0
0
 
0
.4
1
 
C
C
 
9
.4
4
 
1
.0
0
 
2
.7
9
 
0
.6
2
 
0
.0
2
4
 
0
.0
2
4
 
8
.7
4
 
0
.6
1
 
7
9
.0
0
 
0
.4
5
 
3
.0
0
 
0
.4
5
 
b
) A
D
H
1
C
 
S
T
IM
 
S
E
M
 
IL
-2
 
S
E
M
 
IL
-4
 
S
E
M
 
IL
-5
 
S
E
M
 
IL
-1
0
 
S
E
M
 
IF
N
- 
γ 
S
E
M
 
T
T
 
1
3
.8
9
 
4
.5
6
 
2
.0
4
 
0
.8
4
 
8
4
.2
6
 
6
4
.3
9
 
6
8
2
7
.0
0
 
2
9
0
0
.6
3
 
1
.5
8
 
0
.3
6
 
3
.5
7
 
1
.8
4
 
C
T
 
3
8
.1
2
 
1
7
.2
6
 
0
.9
9
 
0
.3
4
 
1
6
.6
1
 
7
.2
6
 
1
2
1
4
.9
4
 
4
4
8
.3
4
 
1
.1
0
 
0
.3
6
 
4
6
.6
9
 
4
5
.4
1
 
C
C
 
8
.0
4
 
3
.9
5
 
1
.0
3
 
0
.4
9
 
2
.9
3
 
0
.4
0
 
2
1
2
6
.6
5
 
1
0
6
4
.5
4
 
2
.2
3
 
0
.6
3
 
2
.1
5
 
1
.3
9
 
c)
 P
E
N
 
W
B
C
 
S
E
M
 
S
E
G
S
 
S
E
M
 
B
A
N
D
S
 
S
E
M
 
R
B
C
 
S
E
M
 
T
O
T
-
P
R
O
T
 
S
E
M
 
F
IB
 
S
E
M
 
9
 
8
.3
3
 
1
.0
1
 
1
.9
4
 
0
.3
6
 
0
.0
0
0
 
0
.0
0
0
 
9
.3
0
 
0
.8
3
 
7
7
.2
5
 
1
.1
1
 
2
.1
3
 
0
.2
1
 
1
0
 
9
.7
6
 
0
.7
1
 
2
.6
6
 
0
.4
2
 
0
.0
2
3
 
0
.0
1
5
 
8
.4
3
 
0
.1
7
 
7
9
.5
0
 
1
.0
0
 
3
.7
0
 
0
.2
1
 
d
) P
E
N
 
S
T
IM
 
S
E
M
 
IL
-2
 
S
E
M
 
IL
-4
 
S
E
M
 
IL
-5
 
S
E
M
 
IL
-1
0
 
S
E
M
 
IF
N
- 
γ 
S
E
M
 
9
 
2
4
.5
3
 
1
9
.1
8
 
2
.7
3
 
0
.9
2
 
7
.6
2
 
3
.7
1
 
3
1
9
8
.9
0
 
1
8
7
4
.0
4
 
1
.5
5
 
0
.3
0
 
3
.3
0
 
1
.5
0
 
1
0
 
1
6
.4
0
 
4
.5
8
 
0
.8
4
 
0
.1
9
 
4
7
.2
0
 
3
2
.9
2
 
3
6
8
3
.2
4
 
1
6
1
9
.9
1
 
1
.7
2
 
0
.3
9
 
2
0
.2
2
 
1
8
.1
0
 
80
e)
 V
A
 (
%
) 
W
B
C
 
S
E
M
 
S
E
G
S
 
S
E
M
 
B
A
N
D
S
 
S
E
M
 
R
B
C
 
S
E
M
 
T
O
T
-
P
R
O
T
 
S
E
M
 
F
IB
 
S
E
M
 
2
5
 
9
.9
1
 
0
.9
7
 
2
.5
5
 
0
.4
7
 
0
.0
3
3
 
0
.0
2
1
 
8
.5
6
 
0
.3
2
 
7
8
.0
0
 
1
.1
5
 
3
.0
0
 
0
.3
1
 
7
5
 
8
.7
9
 
0
.6
7
 
2
.3
6
 
0
.4
8
 
0
.0
0
 
0
.0
0
 
8
.7
9
 
0
.4
5
 
7
9
.7
1
 
1
.1
3
 
3
.4
3
 
0
.4
3
 
f)
 V
A
 
(%
) 
S
T
IM
 
S
E
M
 
IL
-2
 
S
E
M
 
IL
-4
 
S
E
M
 
IL
-5
 
S
E
M
 
IL
-1
0
 
S
E
M
 
IF
N
- 
γ 
S
E
M
 
2
5
 
9
.2
3
 
2
.7
9
 
1
.4
9
 
0
.6
5
 
9
.8
2
 
3
.5
2
 
3
2
7
3
.7
7
 
1
8
.2
8
.9
3
 
1
.9
8
 
0
.4
8
 
2
.8
9
 
1
.3
4
 
7
5
 
2
8
.2
2
 
1
0
.8
1
 
1
.2
7
 
0
.3
8
 
6
1
.9
5
 
4
6
.8
4
 
3
8
1
5
.9
5
 
1
8
0
9
.1
3
 
1
.3
7
 
0
.3
0
 
2
7
.8
8
 
2
5
.8
6
 
A
D
H
1
C
 =
 A
D
H
1
C
c.
-6
4
T
>
C
 g
en
o
ty
p
e;
 P
E
N
 =
 P
en
 a
ll
o
ca
ti
o
n
; 
V
A
 =
 V
it
am
in
 A
 l
ev
el
 a
s 
a 
p
er
ce
n
ta
g
e 
o
f 
th
e 
N
R
C
 (
1
9
9
6
) 
re
q
u
ir
em
en
t;
 W
B
C
 =
 
W
h
it
e 
b
lo
o
d
 c
el
l 
co
u
n
t;
 S
E
M
 =
 S
ta
n
d
ar
d
 e
rr
o
r 
o
f 
th
e 
m
ea
n
; 
S
E
G
S
 =
 S
eg
m
en
te
d
 c
el
l 
co
u
n
t;
 B
A
N
D
S
 =
 B
an
d
 n
eu
tr
o
p
h
il
 c
o
u
n
t;
 R
B
C
 =
 R
ed
 b
lo
o
d
 
ce
ll
 c
o
u
n
t;
 T
O
T
P
R
O
T
 =
 T
o
ta
l 
p
ro
te
in
 c
o
u
n
t;
 F
IB
 =
 F
ib
ri
n
o
g
en
 c
o
u
n
t;
 S
T
IM
 =
 S
ti
m
u
la
ti
o
n
 i
n
d
ex
 v
al
u
e;
 I
L
-2
 =
 I
n
te
rl
eu
k
in
 2
 g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 
ch
an
g
e;
 I
L
-4
 =
 I
n
te
rl
eu
k
in
 4
 g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e;
 I
L
-5
 =
 I
n
te
rl
eu
k
in
 5
 g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e;
 I
L
-1
0
 =
 I
n
te
rl
eu
k
in
 1
0
 g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e;
 I
F
N
-γ
 =
 I
n
te
rf
er
o
n
 g
am
m
a 
g
en
e 
ex
p
re
ss
io
n
 f
o
ld
 c
h
an
g
e
 
81
82 
APPENDIX C 
PAG 2015 Poster: 
Feedlot Performance and Immunology of Beef Steers Fed a Low Vitamin A Diet 
and Selected for ADH1C Genotype 
K.M. Madder1, C.D. Luby2, J.J. McKinnon1, G.W. Torres3 and F.C. Buchanan1 
1College of Agriculture and Bioresources, University of Saskatchewan, Saskatoon, SK, 2Western College of Veterinary 
Medicine, Saskatoon, SK, 3Cattleland Feedyards Ltd, Strathmore, AB. 
Introduction 
References 
Acknowledgements 
Figure 3. Mean Average Daily Gains from rehandling until 
slaughter for pens (n=40) of implanted and non implanted 
crossbred feedlot steers with differing ADH1C genotypes. Bars 
with differing superscripts are significantly different (P<0.05).  
Figure 2. Differential WBC counts in 18 randomly selected 
black Angus X steers of differing ADH1C genotype and dietary 
VA level. Bars with differing superscripts are significantly 
different (P<0.05).  
 Feedlots strive to minimize costs and maximize returns 
and Marker Assisted Management (MAM) is a way in 
which they could accomplish this goal, by managing 
cattle to improve efficiency based on genotype 
 Premiums are possible for those producing consistently 
high-marbling carcasses 
 The TT ADH1Cc.-64T>C genotype has been shown to 
increase intramuscular fat (IMF) when vitamin A (VA) 
is limited in finishing rations1 
 Dietary VA is converted to retinaldehyde (RAL) by 
alcohol dehydrogenase 1 C (ADH1C) and RAL is 
further converted to retinoic acid (RA)1,2,3 
 RA stimulates and RAL inhibits gene expression, 
affecting fat deposition2,3 
 This study aimed to determine whether feeding a 
previously optimized VA level in a commercial feedlot 
setting to TT and CT ADH1C animals would have an 
effect on marbling, as well as observing the effect 
hormonal implants may have on this process, and 
identifying any negative effects on immune function 
Materials and Methods 
Immunology Population: 
 Black Angus X steers – No implants nor growth 
promotants 
 Fed typical commercial backgrounding and finishing 
rations apart from a reduction in VA during finishing 
 Two treatments of vitamin A (25% and 75% of NRC 
recommended 2200 IU/kg DM4) administered via a 
monthly oral bolus 
 Blood samples taken from 18 steers (3 of each 
ADH1C genotype and VA level combination) one 
month before slaughter 
 Differential blood cell counts and PBMC response to 
mitogen assays were conducted  
 Data analyzed as a 3 x 2 factorial (genotype x VA 
treatment) using the mixed method of SAS 9.36 
Production and Carcass Data Population: 
Results  Previous studies using non implanted black Angus X 
steers showed that TT steers should have increased 
intramuscular fat when dietary VA was reduced1 
 There were no significant interaction effects between 
genotype and VA level and no main effects with either 
variable in this study 
 Implant status had many significant main effects on 
both production and carcass data 
 An unexpected, yet significant interaction was 
observed for implant status x ADH1C on Late ADG, 
where CT implanted animals had the highest ADG, 
followed by TT implanted, then by non implanted 
animals 
 Significant differences were observed in the 
immunology population, however no consistent 
pattern suggested that either genotype or VA level or a 
combination of the two was responsible for decreased 
immune function 
• Further investigation is required to determine why the 
expected VA x ADH1C interaction was not observed 
here and to study further the interaction effect on 
ADG 
 qRT-PCR tests are being conducted to study the 
effects of these treatments on immune function 
Figure 1. Treatment design for the Production and Carcass 
Data Population. 2000 mixed breed steers were selected based 
on ADH1C genotype, were separated into pens where they 
were either implanted or not implanted, and received either 
100% or 50% NRC of VA. There were 5 pens of each 
treatment combination, totaling 40 pens. 
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Immunology Data: 
• ADH1C x VA interactions observed for WBC counts 
(P=0.003) and Segmented Cell counts (P=0.010) 
• No significant (P<0.05) main or interaction effects were 
observed for differential Banded Cell counts, RBC 
counts, Total Protein, or Fibrinogen 
• There were also no significant main or interaction 
effects observed on Stimulation Indexes for the PBMC 
response to mitogen assays 
• There were no observable clinical signs of VA 
deficiency in either population of steers 
Discussion and Conclusion 
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Production and Carcass Data: 
• A significant interaction effect of ADH1C x implant 
status on Late ADG (rehandling until finishing; 
P=0.036) was observed 
• Implant status main effects were significant for the 
following traits: DMI, Early ADG, Late ADG, Vision 
Grade US Yield, VG Marbling, VG Fat (all P<0.001), 
and VG REA (P=0.011) 
• No other significant main or interaction effects were
observed 
 Typical commercial backgrounding and finishing 
ration 
 VA added to the feed (either 100% NRC 
recommendation or 50%) during the finishing period  
 Pens sent to slaughter once pen weight average 
reached 1350 lbs. 
 Production data from feedlot and camera grading 
carcass data obtained from slaughter facility 
 Data analyzed as a 2 x 2 x 2 factorial (genotype x VA 
treatment x implant status) using the mixed method of 
SAS 9.36 
